<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVJO" lang="spa" raw_text_char_length="5378" raw_text_md5="959fc1e6da9ab27fc4dfa797a0817b54" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="83" id="segment-0" start_char="1">
<ORIGINAL_TEXT>Ciclosporina, el fármaco que reduce un 81% las probabilidades de morir por COVID-19</ORIGINAL_TEXT>
<TOKEN end_char="12" id="token-0-0" morph="none" pos="word" start_char="1">Ciclosporina</TOKEN>
<TOKEN end_char="13" id="token-0-1" morph="none" pos="punct" start_char="13">,</TOKEN>
<TOKEN end_char="16" id="token-0-2" morph="none" pos="word" start_char="15">el</TOKEN>
<TOKEN end_char="24" id="token-0-3" morph="none" pos="word" start_char="18">fármaco</TOKEN>
<TOKEN end_char="28" id="token-0-4" morph="none" pos="word" start_char="26">que</TOKEN>
<TOKEN end_char="35" id="token-0-5" morph="none" pos="word" start_char="30">reduce</TOKEN>
<TOKEN end_char="38" id="token-0-6" morph="none" pos="word" start_char="37">un</TOKEN>
<TOKEN end_char="41" id="token-0-7" morph="none" pos="word" start_char="40">81</TOKEN>
<TOKEN end_char="42" id="token-0-8" morph="none" pos="punct" start_char="42">%</TOKEN>
<TOKEN end_char="46" id="token-0-9" morph="none" pos="word" start_char="44">las</TOKEN>
<TOKEN end_char="61" id="token-0-10" morph="none" pos="word" start_char="48">probabilidades</TOKEN>
<TOKEN end_char="64" id="token-0-11" morph="none" pos="word" start_char="63">de</TOKEN>
<TOKEN end_char="70" id="token-0-12" morph="none" pos="word" start_char="66">morir</TOKEN>
<TOKEN end_char="74" id="token-0-13" morph="none" pos="word" start_char="72">por</TOKEN>
<TOKEN end_char="83" id="token-0-14" morph="none" pos="unknown" start_char="76">COVID-19</TOKEN>
<TRANSLATED_TEXT>Cyclosporin, the drug that reduces the chances of dying from COVID-19 by 81%</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="175" id="segment-1" start_char="87">
<ORIGINAL_TEXT>La ciclosporina, un tratamiento prometedor para pacientes hospitalizados por la COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="88" id="token-1-0" morph="none" pos="word" start_char="87">La</TOKEN>
<TOKEN end_char="101" id="token-1-1" morph="none" pos="word" start_char="90">ciclosporina</TOKEN>
<TOKEN end_char="102" id="token-1-2" morph="none" pos="punct" start_char="102">,</TOKEN>
<TOKEN end_char="105" id="token-1-3" morph="none" pos="word" start_char="104">un</TOKEN>
<TOKEN end_char="117" id="token-1-4" morph="none" pos="word" start_char="107">tratamiento</TOKEN>
<TOKEN end_char="128" id="token-1-5" morph="none" pos="word" start_char="119">prometedor</TOKEN>
<TOKEN end_char="133" id="token-1-6" morph="none" pos="word" start_char="130">para</TOKEN>
<TOKEN end_char="143" id="token-1-7" morph="none" pos="word" start_char="135">pacientes</TOKEN>
<TOKEN end_char="158" id="token-1-8" morph="none" pos="word" start_char="145">hospitalizados</TOKEN>
<TOKEN end_char="162" id="token-1-9" morph="none" pos="word" start_char="160">por</TOKEN>
<TOKEN end_char="165" id="token-1-10" morph="none" pos="word" start_char="164">la</TOKEN>
<TOKEN end_char="174" id="token-1-11" morph="none" pos="unknown" start_char="167">COVID-19</TOKEN>
<TOKEN end_char="175" id="token-1-12" morph="none" pos="punct" start_char="175">.</TOKEN>
<TRANSLATED_TEXT>Cyclosporin, a promising treatment for patients hospitalized with COVID-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="188" id="segment-2" start_char="177">
<ORIGINAL_TEXT>Europa Press</ORIGINAL_TEXT>
<TOKEN end_char="182" id="token-2-0" morph="none" pos="word" start_char="177">Europa</TOKEN>
<TOKEN end_char="188" id="token-2-1" morph="none" pos="word" start_char="184">Press</TOKEN>
</SEG>
<SEG end_char="367" id="segment-3" start_char="192">
<ORIGINAL_TEXT>Es la principal conclusión de un estudio realizado entre 600 pacientes con coronavirus ingresados en el Hospital Universitario Quirónsalud de Madrid entre marzo y abril de 2020</ORIGINAL_TEXT>
<TOKEN end_char="193" id="token-3-0" morph="none" pos="word" start_char="192">Es</TOKEN>
<TOKEN end_char="196" id="token-3-1" morph="none" pos="word" start_char="195">la</TOKEN>
<TOKEN end_char="206" id="token-3-2" morph="none" pos="word" start_char="198">principal</TOKEN>
<TOKEN end_char="217" id="token-3-3" morph="none" pos="word" start_char="208">conclusión</TOKEN>
<TOKEN end_char="220" id="token-3-4" morph="none" pos="word" start_char="219">de</TOKEN>
<TOKEN end_char="223" id="token-3-5" morph="none" pos="word" start_char="222">un</TOKEN>
<TOKEN end_char="231" id="token-3-6" morph="none" pos="word" start_char="225">estudio</TOKEN>
<TOKEN end_char="241" id="token-3-7" morph="none" pos="word" start_char="233">realizado</TOKEN>
<TOKEN end_char="247" id="token-3-8" morph="none" pos="word" start_char="243">entre</TOKEN>
<TOKEN end_char="251" id="token-3-9" morph="none" pos="word" start_char="249">600</TOKEN>
<TOKEN end_char="261" id="token-3-10" morph="none" pos="word" start_char="253">pacientes</TOKEN>
<TOKEN end_char="265" id="token-3-11" morph="none" pos="word" start_char="263">con</TOKEN>
<TOKEN end_char="277" id="token-3-12" morph="none" pos="word" start_char="267">coronavirus</TOKEN>
<TOKEN end_char="288" id="token-3-13" morph="none" pos="word" start_char="279">ingresados</TOKEN>
<TOKEN end_char="291" id="token-3-14" morph="none" pos="word" start_char="290">en</TOKEN>
<TOKEN end_char="294" id="token-3-15" morph="none" pos="word" start_char="293">el</TOKEN>
<TOKEN end_char="303" id="token-3-16" morph="none" pos="word" start_char="296">Hospital</TOKEN>
<TOKEN end_char="317" id="token-3-17" morph="none" pos="word" start_char="305">Universitario</TOKEN>
<TOKEN end_char="329" id="token-3-18" morph="none" pos="word" start_char="319">Quirónsalud</TOKEN>
<TOKEN end_char="332" id="token-3-19" morph="none" pos="word" start_char="331">de</TOKEN>
<TOKEN end_char="339" id="token-3-20" morph="none" pos="word" start_char="334">Madrid</TOKEN>
<TOKEN end_char="345" id="token-3-21" morph="none" pos="word" start_char="341">entre</TOKEN>
<TOKEN end_char="351" id="token-3-22" morph="none" pos="word" start_char="347">marzo</TOKEN>
<TOKEN end_char="353" id="token-3-23" morph="none" pos="word" start_char="353">y</TOKEN>
<TOKEN end_char="359" id="token-3-24" morph="none" pos="word" start_char="355">abril</TOKEN>
<TOKEN end_char="362" id="token-3-25" morph="none" pos="word" start_char="361">de</TOKEN>
<TOKEN end_char="367" id="token-3-26" morph="none" pos="word" start_char="364">2020</TOKEN>
<TRANSLATED_TEXT>It is the main conclusion of a study conducted among 600 patients with coronavirus admitted to the University Hospital Quironsaldo in Madrid between March and April 2020.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="491" id="segment-4" start_char="370">
<ORIGINAL_TEXT>La supervivencia de los pacientes tratados con ciclosporina fue mayor que la de los enfermos que recibieron otros fármacos</ORIGINAL_TEXT>
<TOKEN end_char="371" id="token-4-0" morph="none" pos="word" start_char="370">La</TOKEN>
<TOKEN end_char="385" id="token-4-1" morph="none" pos="word" start_char="373">supervivencia</TOKEN>
<TOKEN end_char="388" id="token-4-2" morph="none" pos="word" start_char="387">de</TOKEN>
<TOKEN end_char="392" id="token-4-3" morph="none" pos="word" start_char="390">los</TOKEN>
<TOKEN end_char="402" id="token-4-4" morph="none" pos="word" start_char="394">pacientes</TOKEN>
<TOKEN end_char="411" id="token-4-5" morph="none" pos="word" start_char="404">tratados</TOKEN>
<TOKEN end_char="415" id="token-4-6" morph="none" pos="word" start_char="413">con</TOKEN>
<TOKEN end_char="428" id="token-4-7" morph="none" pos="word" start_char="417">ciclosporina</TOKEN>
<TOKEN end_char="432" id="token-4-8" morph="none" pos="word" start_char="430">fue</TOKEN>
<TOKEN end_char="438" id="token-4-9" morph="none" pos="word" start_char="434">mayor</TOKEN>
<TOKEN end_char="442" id="token-4-10" morph="none" pos="word" start_char="440">que</TOKEN>
<TOKEN end_char="445" id="token-4-11" morph="none" pos="word" start_char="444">la</TOKEN>
<TOKEN end_char="448" id="token-4-12" morph="none" pos="word" start_char="447">de</TOKEN>
<TOKEN end_char="452" id="token-4-13" morph="none" pos="word" start_char="450">los</TOKEN>
<TOKEN end_char="461" id="token-4-14" morph="none" pos="word" start_char="454">enfermos</TOKEN>
<TOKEN end_char="465" id="token-4-15" morph="none" pos="word" start_char="463">que</TOKEN>
<TOKEN end_char="476" id="token-4-16" morph="none" pos="word" start_char="467">recibieron</TOKEN>
<TOKEN end_char="482" id="token-4-17" morph="none" pos="word" start_char="478">otros</TOKEN>
<TOKEN end_char="491" id="token-4-18" morph="none" pos="word" start_char="484">fármacos</TOKEN>
<TRANSLATED_TEXT>The survival of patients treated with ciclosporin was higher than that of patients receiving other drugs</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="720" id="segment-5" start_char="495">
<ORIGINAL_TEXT>Los enfermos de coronavirus que fueron tratados con ciclosporina en el Hospital Universitario Quirónsalud Madrid tuvieron un 81 por ciento menos de probabilidad de fallecer que aquellos pacientes que recibieron otros fármacos.</ORIGINAL_TEXT>
<TOKEN end_char="497" id="token-5-0" morph="none" pos="word" start_char="495">Los</TOKEN>
<TOKEN end_char="506" id="token-5-1" morph="none" pos="word" start_char="499">enfermos</TOKEN>
<TOKEN end_char="509" id="token-5-2" morph="none" pos="word" start_char="508">de</TOKEN>
<TOKEN end_char="521" id="token-5-3" morph="none" pos="word" start_char="511">coronavirus</TOKEN>
<TOKEN end_char="525" id="token-5-4" morph="none" pos="word" start_char="523">que</TOKEN>
<TOKEN end_char="532" id="token-5-5" morph="none" pos="word" start_char="527">fueron</TOKEN>
<TOKEN end_char="541" id="token-5-6" morph="none" pos="word" start_char="534">tratados</TOKEN>
<TOKEN end_char="545" id="token-5-7" morph="none" pos="word" start_char="543">con</TOKEN>
<TOKEN end_char="558" id="token-5-8" morph="none" pos="word" start_char="547">ciclosporina</TOKEN>
<TOKEN end_char="561" id="token-5-9" morph="none" pos="word" start_char="560">en</TOKEN>
<TOKEN end_char="564" id="token-5-10" morph="none" pos="word" start_char="563">el</TOKEN>
<TOKEN end_char="573" id="token-5-11" morph="none" pos="word" start_char="566">Hospital</TOKEN>
<TOKEN end_char="587" id="token-5-12" morph="none" pos="word" start_char="575">Universitario</TOKEN>
<TOKEN end_char="599" id="token-5-13" morph="none" pos="word" start_char="589">Quirónsalud</TOKEN>
<TOKEN end_char="606" id="token-5-14" morph="none" pos="word" start_char="601">Madrid</TOKEN>
<TOKEN end_char="615" id="token-5-15" morph="none" pos="word" start_char="608">tuvieron</TOKEN>
<TOKEN end_char="618" id="token-5-16" morph="none" pos="word" start_char="617">un</TOKEN>
<TOKEN end_char="621" id="token-5-17" morph="none" pos="word" start_char="620">81</TOKEN>
<TOKEN end_char="625" id="token-5-18" morph="none" pos="word" start_char="623">por</TOKEN>
<TOKEN end_char="632" id="token-5-19" morph="none" pos="word" start_char="627">ciento</TOKEN>
<TOKEN end_char="638" id="token-5-20" morph="none" pos="word" start_char="634">menos</TOKEN>
<TOKEN end_char="641" id="token-5-21" morph="none" pos="word" start_char="640">de</TOKEN>
<TOKEN end_char="654" id="token-5-22" morph="none" pos="word" start_char="643">probabilidad</TOKEN>
<TOKEN end_char="657" id="token-5-23" morph="none" pos="word" start_char="656">de</TOKEN>
<TOKEN end_char="666" id="token-5-24" morph="none" pos="word" start_char="659">fallecer</TOKEN>
<TOKEN end_char="670" id="token-5-25" morph="none" pos="word" start_char="668">que</TOKEN>
<TOKEN end_char="679" id="token-5-26" morph="none" pos="word" start_char="672">aquellos</TOKEN>
<TOKEN end_char="689" id="token-5-27" morph="none" pos="word" start_char="681">pacientes</TOKEN>
<TOKEN end_char="693" id="token-5-28" morph="none" pos="word" start_char="691">que</TOKEN>
<TOKEN end_char="704" id="token-5-29" morph="none" pos="word" start_char="695">recibieron</TOKEN>
<TOKEN end_char="710" id="token-5-30" morph="none" pos="word" start_char="706">otros</TOKEN>
<TOKEN end_char="719" id="token-5-31" morph="none" pos="word" start_char="712">fármacos</TOKEN>
<TOKEN end_char="720" id="token-5-32" morph="none" pos="punct" start_char="720">.</TOKEN>
<TRANSLATED_TEXT>Coronavirus patients who were treated with ciclosporin at the University Hospital QuironHealth Madrid had an 81% less chance of dying than patients who received other drugs.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1093" id="segment-6" start_char="722">
<ORIGINAL_TEXT>Es la principal conclusión a la que ha llegado el Grupo de Investigación en COVID-19, liderado por el Servicio de Medicina Interna de este hospital, junto con la Universidad Europea, tras realizar un estudio en el que han analizado los tratamientos que recibieron más de 600 pacientes ingresados en este centro sanitario, desde el 10 de marzo hasta el 15 de abril de 2020.</ORIGINAL_TEXT>
<TOKEN end_char="723" id="token-6-0" morph="none" pos="word" start_char="722">Es</TOKEN>
<TOKEN end_char="726" id="token-6-1" morph="none" pos="word" start_char="725">la</TOKEN>
<TOKEN end_char="736" id="token-6-2" morph="none" pos="word" start_char="728">principal</TOKEN>
<TOKEN end_char="747" id="token-6-3" morph="none" pos="word" start_char="738">conclusión</TOKEN>
<TOKEN end_char="749" id="token-6-4" morph="none" pos="word" start_char="749">a</TOKEN>
<TOKEN end_char="752" id="token-6-5" morph="none" pos="word" start_char="751">la</TOKEN>
<TOKEN end_char="756" id="token-6-6" morph="none" pos="word" start_char="754">que</TOKEN>
<TOKEN end_char="759" id="token-6-7" morph="none" pos="word" start_char="758">ha</TOKEN>
<TOKEN end_char="767" id="token-6-8" morph="none" pos="word" start_char="761">llegado</TOKEN>
<TOKEN end_char="770" id="token-6-9" morph="none" pos="word" start_char="769">el</TOKEN>
<TOKEN end_char="776" id="token-6-10" morph="none" pos="word" start_char="772">Grupo</TOKEN>
<TOKEN end_char="779" id="token-6-11" morph="none" pos="word" start_char="778">de</TOKEN>
<TOKEN end_char="793" id="token-6-12" morph="none" pos="word" start_char="781">Investigación</TOKEN>
<TOKEN end_char="796" id="token-6-13" morph="none" pos="word" start_char="795">en</TOKEN>
<TOKEN end_char="805" id="token-6-14" morph="none" pos="unknown" start_char="798">COVID-19</TOKEN>
<TOKEN end_char="806" id="token-6-15" morph="none" pos="punct" start_char="806">,</TOKEN>
<TOKEN end_char="815" id="token-6-16" morph="none" pos="word" start_char="808">liderado</TOKEN>
<TOKEN end_char="819" id="token-6-17" morph="none" pos="word" start_char="817">por</TOKEN>
<TOKEN end_char="822" id="token-6-18" morph="none" pos="word" start_char="821">el</TOKEN>
<TOKEN end_char="831" id="token-6-19" morph="none" pos="word" start_char="824">Servicio</TOKEN>
<TOKEN end_char="834" id="token-6-20" morph="none" pos="word" start_char="833">de</TOKEN>
<TOKEN end_char="843" id="token-6-21" morph="none" pos="word" start_char="836">Medicina</TOKEN>
<TOKEN end_char="851" id="token-6-22" morph="none" pos="word" start_char="845">Interna</TOKEN>
<TOKEN end_char="854" id="token-6-23" morph="none" pos="word" start_char="853">de</TOKEN>
<TOKEN end_char="859" id="token-6-24" morph="none" pos="word" start_char="856">este</TOKEN>
<TOKEN end_char="868" id="token-6-25" morph="none" pos="word" start_char="861">hospital</TOKEN>
<TOKEN end_char="869" id="token-6-26" morph="none" pos="punct" start_char="869">,</TOKEN>
<TOKEN end_char="875" id="token-6-27" morph="none" pos="word" start_char="871">junto</TOKEN>
<TOKEN end_char="879" id="token-6-28" morph="none" pos="word" start_char="877">con</TOKEN>
<TOKEN end_char="882" id="token-6-29" morph="none" pos="word" start_char="881">la</TOKEN>
<TOKEN end_char="894" id="token-6-30" morph="none" pos="word" start_char="884">Universidad</TOKEN>
<TOKEN end_char="902" id="token-6-31" morph="none" pos="word" start_char="896">Europea</TOKEN>
<TOKEN end_char="903" id="token-6-32" morph="none" pos="punct" start_char="903">,</TOKEN>
<TOKEN end_char="908" id="token-6-33" morph="none" pos="word" start_char="905">tras</TOKEN>
<TOKEN end_char="917" id="token-6-34" morph="none" pos="word" start_char="910">realizar</TOKEN>
<TOKEN end_char="920" id="token-6-35" morph="none" pos="word" start_char="919">un</TOKEN>
<TOKEN end_char="928" id="token-6-36" morph="none" pos="word" start_char="922">estudio</TOKEN>
<TOKEN end_char="931" id="token-6-37" morph="none" pos="word" start_char="930">en</TOKEN>
<TOKEN end_char="934" id="token-6-38" morph="none" pos="word" start_char="933">el</TOKEN>
<TOKEN end_char="938" id="token-6-39" morph="none" pos="word" start_char="936">que</TOKEN>
<TOKEN end_char="942" id="token-6-40" morph="none" pos="word" start_char="940">han</TOKEN>
<TOKEN end_char="952" id="token-6-41" morph="none" pos="word" start_char="944">analizado</TOKEN>
<TOKEN end_char="956" id="token-6-42" morph="none" pos="word" start_char="954">los</TOKEN>
<TOKEN end_char="969" id="token-6-43" morph="none" pos="word" start_char="958">tratamientos</TOKEN>
<TOKEN end_char="973" id="token-6-44" morph="none" pos="word" start_char="971">que</TOKEN>
<TOKEN end_char="984" id="token-6-45" morph="none" pos="word" start_char="975">recibieron</TOKEN>
<TOKEN end_char="988" id="token-6-46" morph="none" pos="word" start_char="986">más</TOKEN>
<TOKEN end_char="991" id="token-6-47" morph="none" pos="word" start_char="990">de</TOKEN>
<TOKEN end_char="995" id="token-6-48" morph="none" pos="word" start_char="993">600</TOKEN>
<TOKEN end_char="1005" id="token-6-49" morph="none" pos="word" start_char="997">pacientes</TOKEN>
<TOKEN end_char="1016" id="token-6-50" morph="none" pos="word" start_char="1007">ingresados</TOKEN>
<TOKEN end_char="1019" id="token-6-51" morph="none" pos="word" start_char="1018">en</TOKEN>
<TOKEN end_char="1024" id="token-6-52" morph="none" pos="word" start_char="1021">este</TOKEN>
<TOKEN end_char="1031" id="token-6-53" morph="none" pos="word" start_char="1026">centro</TOKEN>
<TOKEN end_char="1041" id="token-6-54" morph="none" pos="word" start_char="1033">sanitario</TOKEN>
<TOKEN end_char="1042" id="token-6-55" morph="none" pos="punct" start_char="1042">,</TOKEN>
<TOKEN end_char="1048" id="token-6-56" morph="none" pos="word" start_char="1044">desde</TOKEN>
<TOKEN end_char="1051" id="token-6-57" morph="none" pos="word" start_char="1050">el</TOKEN>
<TOKEN end_char="1054" id="token-6-58" morph="none" pos="word" start_char="1053">10</TOKEN>
<TOKEN end_char="1057" id="token-6-59" morph="none" pos="word" start_char="1056">de</TOKEN>
<TOKEN end_char="1063" id="token-6-60" morph="none" pos="word" start_char="1059">marzo</TOKEN>
<TOKEN end_char="1069" id="token-6-61" morph="none" pos="word" start_char="1065">hasta</TOKEN>
<TOKEN end_char="1072" id="token-6-62" morph="none" pos="word" start_char="1071">el</TOKEN>
<TOKEN end_char="1075" id="token-6-63" morph="none" pos="word" start_char="1074">15</TOKEN>
<TOKEN end_char="1078" id="token-6-64" morph="none" pos="word" start_char="1077">de</TOKEN>
<TOKEN end_char="1084" id="token-6-65" morph="none" pos="word" start_char="1080">abril</TOKEN>
<TOKEN end_char="1087" id="token-6-66" morph="none" pos="word" start_char="1086">de</TOKEN>
<TOKEN end_char="1092" id="token-6-67" morph="none" pos="word" start_char="1089">2020</TOKEN>
<TOKEN end_char="1093" id="token-6-68" morph="none" pos="punct" start_char="1093">.</TOKEN>
<TRANSLATED_TEXT>This is the main conclusion reached by the COVID-19 Research Group, led by the Internal Medicine Service of this hospital, together with the European University, following a study in which they have analysed the treatments received by more than 600 patients admitted to this health centre, from 10 March to 15 April 2020.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1231" id="segment-7" start_char="1096">
<ORIGINAL_TEXT>"Los pacientes incluidos en este estudio sufrían afectación respiratoria suficientemente importante para necesitar ingreso hospitalario.</ORIGINAL_TEXT>
<TOKEN end_char="1096" id="token-7-0" morph="none" pos="punct" start_char="1096">"</TOKEN>
<TOKEN end_char="1099" id="token-7-1" morph="none" pos="word" start_char="1097">Los</TOKEN>
<TOKEN end_char="1109" id="token-7-2" morph="none" pos="word" start_char="1101">pacientes</TOKEN>
<TOKEN end_char="1119" id="token-7-3" morph="none" pos="word" start_char="1111">incluidos</TOKEN>
<TOKEN end_char="1122" id="token-7-4" morph="none" pos="word" start_char="1121">en</TOKEN>
<TOKEN end_char="1127" id="token-7-5" morph="none" pos="word" start_char="1124">este</TOKEN>
<TOKEN end_char="1135" id="token-7-6" morph="none" pos="word" start_char="1129">estudio</TOKEN>
<TOKEN end_char="1143" id="token-7-7" morph="none" pos="word" start_char="1137">sufrían</TOKEN>
<TOKEN end_char="1154" id="token-7-8" morph="none" pos="word" start_char="1145">afectación</TOKEN>
<TOKEN end_char="1167" id="token-7-9" morph="none" pos="word" start_char="1156">respiratoria</TOKEN>
<TOKEN end_char="1183" id="token-7-10" morph="none" pos="word" start_char="1169">suficientemente</TOKEN>
<TOKEN end_char="1194" id="token-7-11" morph="none" pos="word" start_char="1185">importante</TOKEN>
<TOKEN end_char="1199" id="token-7-12" morph="none" pos="word" start_char="1196">para</TOKEN>
<TOKEN end_char="1209" id="token-7-13" morph="none" pos="word" start_char="1201">necesitar</TOKEN>
<TOKEN end_char="1217" id="token-7-14" morph="none" pos="word" start_char="1211">ingreso</TOKEN>
<TOKEN end_char="1230" id="token-7-15" morph="none" pos="word" start_char="1219">hospitalario</TOKEN>
<TOKEN end_char="1231" id="token-7-16" morph="none" pos="punct" start_char="1231">.</TOKEN>
<TRANSLATED_TEXT>The patients included in this study suffered sufficiently severe respiratory impairment to require hospital admission.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1323" id="segment-8" start_char="1233">
<ORIGINAL_TEXT>Hemos analizado sus características clínicas y hemos analizado tratamientos que recibieron.</ORIGINAL_TEXT>
<TOKEN end_char="1237" id="token-8-0" morph="none" pos="word" start_char="1233">Hemos</TOKEN>
<TOKEN end_char="1247" id="token-8-1" morph="none" pos="word" start_char="1239">analizado</TOKEN>
<TOKEN end_char="1251" id="token-8-2" morph="none" pos="word" start_char="1249">sus</TOKEN>
<TOKEN end_char="1267" id="token-8-3" morph="none" pos="word" start_char="1253">características</TOKEN>
<TOKEN end_char="1276" id="token-8-4" morph="none" pos="word" start_char="1269">clínicas</TOKEN>
<TOKEN end_char="1278" id="token-8-5" morph="none" pos="word" start_char="1278">y</TOKEN>
<TOKEN end_char="1284" id="token-8-6" morph="none" pos="word" start_char="1280">hemos</TOKEN>
<TOKEN end_char="1294" id="token-8-7" morph="none" pos="word" start_char="1286">analizado</TOKEN>
<TOKEN end_char="1307" id="token-8-8" morph="none" pos="word" start_char="1296">tratamientos</TOKEN>
<TOKEN end_char="1311" id="token-8-9" morph="none" pos="word" start_char="1309">que</TOKEN>
<TOKEN end_char="1322" id="token-8-10" morph="none" pos="word" start_char="1313">recibieron</TOKEN>
<TOKEN end_char="1323" id="token-8-11" morph="none" pos="punct" start_char="1323">.</TOKEN>
<TRANSLATED_TEXT>We've analyzed their clinical characteristics and analyzed the treatments they received.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1536" id="segment-9" start_char="1325">
<ORIGINAL_TEXT>Nuestros pacientes no difieren en las características de otras series publicadas y los factores pronósticos son similares (edad, gravedad y extensión de la afectación pulmonar y algunos parámetros inflamatorios).</ORIGINAL_TEXT>
<TOKEN end_char="1332" id="token-9-0" morph="none" pos="word" start_char="1325">Nuestros</TOKEN>
<TOKEN end_char="1342" id="token-9-1" morph="none" pos="word" start_char="1334">pacientes</TOKEN>
<TOKEN end_char="1345" id="token-9-2" morph="none" pos="word" start_char="1344">no</TOKEN>
<TOKEN end_char="1354" id="token-9-3" morph="none" pos="word" start_char="1347">difieren</TOKEN>
<TOKEN end_char="1357" id="token-9-4" morph="none" pos="word" start_char="1356">en</TOKEN>
<TOKEN end_char="1361" id="token-9-5" morph="none" pos="word" start_char="1359">las</TOKEN>
<TOKEN end_char="1377" id="token-9-6" morph="none" pos="word" start_char="1363">características</TOKEN>
<TOKEN end_char="1380" id="token-9-7" morph="none" pos="word" start_char="1379">de</TOKEN>
<TOKEN end_char="1386" id="token-9-8" morph="none" pos="word" start_char="1382">otras</TOKEN>
<TOKEN end_char="1393" id="token-9-9" morph="none" pos="word" start_char="1388">series</TOKEN>
<TOKEN end_char="1404" id="token-9-10" morph="none" pos="word" start_char="1395">publicadas</TOKEN>
<TOKEN end_char="1406" id="token-9-11" morph="none" pos="word" start_char="1406">y</TOKEN>
<TOKEN end_char="1410" id="token-9-12" morph="none" pos="word" start_char="1408">los</TOKEN>
<TOKEN end_char="1419" id="token-9-13" morph="none" pos="word" start_char="1412">factores</TOKEN>
<TOKEN end_char="1431" id="token-9-14" morph="none" pos="word" start_char="1421">pronósticos</TOKEN>
<TOKEN end_char="1435" id="token-9-15" morph="none" pos="word" start_char="1433">son</TOKEN>
<TOKEN end_char="1445" id="token-9-16" morph="none" pos="word" start_char="1437">similares</TOKEN>
<TOKEN end_char="1447" id="token-9-17" morph="none" pos="punct" start_char="1447">(</TOKEN>
<TOKEN end_char="1451" id="token-9-18" morph="none" pos="word" start_char="1448">edad</TOKEN>
<TOKEN end_char="1452" id="token-9-19" morph="none" pos="punct" start_char="1452">,</TOKEN>
<TOKEN end_char="1461" id="token-9-20" morph="none" pos="word" start_char="1454">gravedad</TOKEN>
<TOKEN end_char="1463" id="token-9-21" morph="none" pos="word" start_char="1463">y</TOKEN>
<TOKEN end_char="1473" id="token-9-22" morph="none" pos="word" start_char="1465">extensión</TOKEN>
<TOKEN end_char="1476" id="token-9-23" morph="none" pos="word" start_char="1475">de</TOKEN>
<TOKEN end_char="1479" id="token-9-24" morph="none" pos="word" start_char="1478">la</TOKEN>
<TOKEN end_char="1490" id="token-9-25" morph="none" pos="word" start_char="1481">afectación</TOKEN>
<TOKEN end_char="1499" id="token-9-26" morph="none" pos="word" start_char="1492">pulmonar</TOKEN>
<TOKEN end_char="1501" id="token-9-27" morph="none" pos="word" start_char="1501">y</TOKEN>
<TOKEN end_char="1509" id="token-9-28" morph="none" pos="word" start_char="1503">algunos</TOKEN>
<TOKEN end_char="1520" id="token-9-29" morph="none" pos="word" start_char="1511">parámetros</TOKEN>
<TOKEN end_char="1534" id="token-9-30" morph="none" pos="word" start_char="1522">inflamatorios</TOKEN>
<TOKEN end_char="1536" id="token-9-31" morph="none" pos="punct" start_char="1535">).</TOKEN>
<TRANSLATED_TEXT>Our patients do not differ in the characteristics of other published series and the prognostic factors are similar (age, severity and extent of lung affect and some inflammatory parameters)...............</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2083" id="segment-10" start_char="1538">
<ORIGINAL_TEXT>En relación con los tratamientos recibidos hemos descubierto que la supervivencia de los pacientes que fueron tratados con ciclosporina era mayor respecto a los enfermos que no fueron tratados con este tratamiento.De hecho, en nuestra serie, los pacientes que recibieron ciclosporina tuvieron un 81 por ciento menos de probabilidad de fallecer que los pacientes que no recibieron este tratamiento", explica Daniel Carnevali, jefe del Servicio de Medicina Interna del Hospital Universitario Quirónsalud Madrid y profesor de la Universidad Europea.</ORIGINAL_TEXT>
<TOKEN end_char="1539" id="token-10-0" morph="none" pos="word" start_char="1538">En</TOKEN>
<TOKEN end_char="1548" id="token-10-1" morph="none" pos="word" start_char="1541">relación</TOKEN>
<TOKEN end_char="1552" id="token-10-2" morph="none" pos="word" start_char="1550">con</TOKEN>
<TOKEN end_char="1556" id="token-10-3" morph="none" pos="word" start_char="1554">los</TOKEN>
<TOKEN end_char="1569" id="token-10-4" morph="none" pos="word" start_char="1558">tratamientos</TOKEN>
<TOKEN end_char="1579" id="token-10-5" morph="none" pos="word" start_char="1571">recibidos</TOKEN>
<TOKEN end_char="1585" id="token-10-6" morph="none" pos="word" start_char="1581">hemos</TOKEN>
<TOKEN end_char="1597" id="token-10-7" morph="none" pos="word" start_char="1587">descubierto</TOKEN>
<TOKEN end_char="1601" id="token-10-8" morph="none" pos="word" start_char="1599">que</TOKEN>
<TOKEN end_char="1604" id="token-10-9" morph="none" pos="word" start_char="1603">la</TOKEN>
<TOKEN end_char="1618" id="token-10-10" morph="none" pos="word" start_char="1606">supervivencia</TOKEN>
<TOKEN end_char="1621" id="token-10-11" morph="none" pos="word" start_char="1620">de</TOKEN>
<TOKEN end_char="1625" id="token-10-12" morph="none" pos="word" start_char="1623">los</TOKEN>
<TOKEN end_char="1635" id="token-10-13" morph="none" pos="word" start_char="1627">pacientes</TOKEN>
<TOKEN end_char="1639" id="token-10-14" morph="none" pos="word" start_char="1637">que</TOKEN>
<TOKEN end_char="1646" id="token-10-15" morph="none" pos="word" start_char="1641">fueron</TOKEN>
<TOKEN end_char="1655" id="token-10-16" morph="none" pos="word" start_char="1648">tratados</TOKEN>
<TOKEN end_char="1659" id="token-10-17" morph="none" pos="word" start_char="1657">con</TOKEN>
<TOKEN end_char="1672" id="token-10-18" morph="none" pos="word" start_char="1661">ciclosporina</TOKEN>
<TOKEN end_char="1676" id="token-10-19" morph="none" pos="word" start_char="1674">era</TOKEN>
<TOKEN end_char="1682" id="token-10-20" morph="none" pos="word" start_char="1678">mayor</TOKEN>
<TOKEN end_char="1691" id="token-10-21" morph="none" pos="word" start_char="1684">respecto</TOKEN>
<TOKEN end_char="1693" id="token-10-22" morph="none" pos="word" start_char="1693">a</TOKEN>
<TOKEN end_char="1697" id="token-10-23" morph="none" pos="word" start_char="1695">los</TOKEN>
<TOKEN end_char="1706" id="token-10-24" morph="none" pos="word" start_char="1699">enfermos</TOKEN>
<TOKEN end_char="1710" id="token-10-25" morph="none" pos="word" start_char="1708">que</TOKEN>
<TOKEN end_char="1713" id="token-10-26" morph="none" pos="word" start_char="1712">no</TOKEN>
<TOKEN end_char="1720" id="token-10-27" morph="none" pos="word" start_char="1715">fueron</TOKEN>
<TOKEN end_char="1729" id="token-10-28" morph="none" pos="word" start_char="1722">tratados</TOKEN>
<TOKEN end_char="1733" id="token-10-29" morph="none" pos="word" start_char="1731">con</TOKEN>
<TOKEN end_char="1738" id="token-10-30" morph="none" pos="word" start_char="1735">este</TOKEN>
<TOKEN end_char="1753" id="token-10-31" morph="none" pos="unknown" start_char="1740">tratamiento.De</TOKEN>
<TOKEN end_char="1759" id="token-10-32" morph="none" pos="word" start_char="1755">hecho</TOKEN>
<TOKEN end_char="1760" id="token-10-33" morph="none" pos="punct" start_char="1760">,</TOKEN>
<TOKEN end_char="1763" id="token-10-34" morph="none" pos="word" start_char="1762">en</TOKEN>
<TOKEN end_char="1771" id="token-10-35" morph="none" pos="word" start_char="1765">nuestra</TOKEN>
<TOKEN end_char="1777" id="token-10-36" morph="none" pos="word" start_char="1773">serie</TOKEN>
<TOKEN end_char="1778" id="token-10-37" morph="none" pos="punct" start_char="1778">,</TOKEN>
<TOKEN end_char="1782" id="token-10-38" morph="none" pos="word" start_char="1780">los</TOKEN>
<TOKEN end_char="1792" id="token-10-39" morph="none" pos="word" start_char="1784">pacientes</TOKEN>
<TOKEN end_char="1796" id="token-10-40" morph="none" pos="word" start_char="1794">que</TOKEN>
<TOKEN end_char="1807" id="token-10-41" morph="none" pos="word" start_char="1798">recibieron</TOKEN>
<TOKEN end_char="1820" id="token-10-42" morph="none" pos="word" start_char="1809">ciclosporina</TOKEN>
<TOKEN end_char="1829" id="token-10-43" morph="none" pos="word" start_char="1822">tuvieron</TOKEN>
<TOKEN end_char="1832" id="token-10-44" morph="none" pos="word" start_char="1831">un</TOKEN>
<TOKEN end_char="1835" id="token-10-45" morph="none" pos="word" start_char="1834">81</TOKEN>
<TOKEN end_char="1839" id="token-10-46" morph="none" pos="word" start_char="1837">por</TOKEN>
<TOKEN end_char="1846" id="token-10-47" morph="none" pos="word" start_char="1841">ciento</TOKEN>
<TOKEN end_char="1852" id="token-10-48" morph="none" pos="word" start_char="1848">menos</TOKEN>
<TOKEN end_char="1855" id="token-10-49" morph="none" pos="word" start_char="1854">de</TOKEN>
<TOKEN end_char="1868" id="token-10-50" morph="none" pos="word" start_char="1857">probabilidad</TOKEN>
<TOKEN end_char="1871" id="token-10-51" morph="none" pos="word" start_char="1870">de</TOKEN>
<TOKEN end_char="1880" id="token-10-52" morph="none" pos="word" start_char="1873">fallecer</TOKEN>
<TOKEN end_char="1884" id="token-10-53" morph="none" pos="word" start_char="1882">que</TOKEN>
<TOKEN end_char="1888" id="token-10-54" morph="none" pos="word" start_char="1886">los</TOKEN>
<TOKEN end_char="1898" id="token-10-55" morph="none" pos="word" start_char="1890">pacientes</TOKEN>
<TOKEN end_char="1902" id="token-10-56" morph="none" pos="word" start_char="1900">que</TOKEN>
<TOKEN end_char="1905" id="token-10-57" morph="none" pos="word" start_char="1904">no</TOKEN>
<TOKEN end_char="1916" id="token-10-58" morph="none" pos="word" start_char="1907">recibieron</TOKEN>
<TOKEN end_char="1921" id="token-10-59" morph="none" pos="word" start_char="1918">este</TOKEN>
<TOKEN end_char="1933" id="token-10-60" morph="none" pos="word" start_char="1923">tratamiento</TOKEN>
<TOKEN end_char="1935" id="token-10-61" morph="none" pos="punct" start_char="1934">",</TOKEN>
<TOKEN end_char="1943" id="token-10-62" morph="none" pos="word" start_char="1937">explica</TOKEN>
<TOKEN end_char="1950" id="token-10-63" morph="none" pos="word" start_char="1945">Daniel</TOKEN>
<TOKEN end_char="1960" id="token-10-64" morph="none" pos="word" start_char="1952">Carnevali</TOKEN>
<TOKEN end_char="1961" id="token-10-65" morph="none" pos="punct" start_char="1961">,</TOKEN>
<TOKEN end_char="1966" id="token-10-66" morph="none" pos="word" start_char="1963">jefe</TOKEN>
<TOKEN end_char="1970" id="token-10-67" morph="none" pos="word" start_char="1968">del</TOKEN>
<TOKEN end_char="1979" id="token-10-68" morph="none" pos="word" start_char="1972">Servicio</TOKEN>
<TOKEN end_char="1982" id="token-10-69" morph="none" pos="word" start_char="1981">de</TOKEN>
<TOKEN end_char="1991" id="token-10-70" morph="none" pos="word" start_char="1984">Medicina</TOKEN>
<TOKEN end_char="1999" id="token-10-71" morph="none" pos="word" start_char="1993">Interna</TOKEN>
<TOKEN end_char="2003" id="token-10-72" morph="none" pos="word" start_char="2001">del</TOKEN>
<TOKEN end_char="2012" id="token-10-73" morph="none" pos="word" start_char="2005">Hospital</TOKEN>
<TOKEN end_char="2026" id="token-10-74" morph="none" pos="word" start_char="2014">Universitario</TOKEN>
<TOKEN end_char="2038" id="token-10-75" morph="none" pos="word" start_char="2028">Quirónsalud</TOKEN>
<TOKEN end_char="2045" id="token-10-76" morph="none" pos="word" start_char="2040">Madrid</TOKEN>
<TOKEN end_char="2047" id="token-10-77" morph="none" pos="word" start_char="2047">y</TOKEN>
<TOKEN end_char="2056" id="token-10-78" morph="none" pos="word" start_char="2049">profesor</TOKEN>
<TOKEN end_char="2059" id="token-10-79" morph="none" pos="word" start_char="2058">de</TOKEN>
<TOKEN end_char="2062" id="token-10-80" morph="none" pos="word" start_char="2061">la</TOKEN>
<TOKEN end_char="2074" id="token-10-81" morph="none" pos="word" start_char="2064">Universidad</TOKEN>
<TOKEN end_char="2082" id="token-10-82" morph="none" pos="word" start_char="2076">Europea</TOKEN>
<TOKEN end_char="2083" id="token-10-83" morph="none" pos="punct" start_char="2083">.</TOKEN>
<TRANSLATED_TEXT>In relation to the treatments received, we have found that the survival of patients who were treated with ciclosporin was higher than those who were not treated with ciclosporin. In fact, in our series, patients who received ciclosporin were 81% less likely to die than patients who were not treated with ciclosporin, "explains Daniel Carnevali, head of the Internal Medicine Service of the University Hospital Quirónsolado Madrid and professor at the European University.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2220" id="segment-11" start_char="2086">
<ORIGINAL_TEXT>El COVID-19 posee una doble patogenia: la primera procede de su replicación viral y se produce en las primeras etapas de la enfermedad.</ORIGINAL_TEXT>
<TOKEN end_char="2087" id="token-11-0" morph="none" pos="word" start_char="2086">El</TOKEN>
<TOKEN end_char="2096" id="token-11-1" morph="none" pos="unknown" start_char="2089">COVID-19</TOKEN>
<TOKEN end_char="2102" id="token-11-2" morph="none" pos="word" start_char="2098">posee</TOKEN>
<TOKEN end_char="2106" id="token-11-3" morph="none" pos="word" start_char="2104">una</TOKEN>
<TOKEN end_char="2112" id="token-11-4" morph="none" pos="word" start_char="2108">doble</TOKEN>
<TOKEN end_char="2122" id="token-11-5" morph="none" pos="word" start_char="2114">patogenia</TOKEN>
<TOKEN end_char="2123" id="token-11-6" morph="none" pos="punct" start_char="2123">:</TOKEN>
<TOKEN end_char="2126" id="token-11-7" morph="none" pos="word" start_char="2125">la</TOKEN>
<TOKEN end_char="2134" id="token-11-8" morph="none" pos="word" start_char="2128">primera</TOKEN>
<TOKEN end_char="2142" id="token-11-9" morph="none" pos="word" start_char="2136">procede</TOKEN>
<TOKEN end_char="2145" id="token-11-10" morph="none" pos="word" start_char="2144">de</TOKEN>
<TOKEN end_char="2148" id="token-11-11" morph="none" pos="word" start_char="2147">su</TOKEN>
<TOKEN end_char="2160" id="token-11-12" morph="none" pos="word" start_char="2150">replicación</TOKEN>
<TOKEN end_char="2166" id="token-11-13" morph="none" pos="word" start_char="2162">viral</TOKEN>
<TOKEN end_char="2168" id="token-11-14" morph="none" pos="word" start_char="2168">y</TOKEN>
<TOKEN end_char="2171" id="token-11-15" morph="none" pos="word" start_char="2170">se</TOKEN>
<TOKEN end_char="2179" id="token-11-16" morph="none" pos="word" start_char="2173">produce</TOKEN>
<TOKEN end_char="2182" id="token-11-17" morph="none" pos="word" start_char="2181">en</TOKEN>
<TOKEN end_char="2186" id="token-11-18" morph="none" pos="word" start_char="2184">las</TOKEN>
<TOKEN end_char="2195" id="token-11-19" morph="none" pos="word" start_char="2188">primeras</TOKEN>
<TOKEN end_char="2202" id="token-11-20" morph="none" pos="word" start_char="2197">etapas</TOKEN>
<TOKEN end_char="2205" id="token-11-21" morph="none" pos="word" start_char="2204">de</TOKEN>
<TOKEN end_char="2208" id="token-11-22" morph="none" pos="word" start_char="2207">la</TOKEN>
<TOKEN end_char="2219" id="token-11-23" morph="none" pos="word" start_char="2210">enfermedad</TOKEN>
<TOKEN end_char="2220" id="token-11-24" morph="none" pos="punct" start_char="2220">.</TOKEN>
<TRANSLATED_TEXT>COVID-19 has a double pathogenicity: the first comes from its viral replication and occurs in the early stages of the disease.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2408" id="segment-12" start_char="2222">
<ORIGINAL_TEXT>Entre el octavo y el décimo día, algunos pacientes desarrollan neumonía y predomina un efecto inflamatorio en el que la propia respuesta inmunológica del enfermo es la que daña al pulmón.</ORIGINAL_TEXT>
<TOKEN end_char="2226" id="token-12-0" morph="none" pos="word" start_char="2222">Entre</TOKEN>
<TOKEN end_char="2229" id="token-12-1" morph="none" pos="word" start_char="2228">el</TOKEN>
<TOKEN end_char="2236" id="token-12-2" morph="none" pos="word" start_char="2231">octavo</TOKEN>
<TOKEN end_char="2238" id="token-12-3" morph="none" pos="word" start_char="2238">y</TOKEN>
<TOKEN end_char="2241" id="token-12-4" morph="none" pos="word" start_char="2240">el</TOKEN>
<TOKEN end_char="2248" id="token-12-5" morph="none" pos="word" start_char="2243">décimo</TOKEN>
<TOKEN end_char="2252" id="token-12-6" morph="none" pos="word" start_char="2250">día</TOKEN>
<TOKEN end_char="2253" id="token-12-7" morph="none" pos="punct" start_char="2253">,</TOKEN>
<TOKEN end_char="2261" id="token-12-8" morph="none" pos="word" start_char="2255">algunos</TOKEN>
<TOKEN end_char="2271" id="token-12-9" morph="none" pos="word" start_char="2263">pacientes</TOKEN>
<TOKEN end_char="2283" id="token-12-10" morph="none" pos="word" start_char="2273">desarrollan</TOKEN>
<TOKEN end_char="2292" id="token-12-11" morph="none" pos="word" start_char="2285">neumonía</TOKEN>
<TOKEN end_char="2294" id="token-12-12" morph="none" pos="word" start_char="2294">y</TOKEN>
<TOKEN end_char="2304" id="token-12-13" morph="none" pos="word" start_char="2296">predomina</TOKEN>
<TOKEN end_char="2307" id="token-12-14" morph="none" pos="word" start_char="2306">un</TOKEN>
<TOKEN end_char="2314" id="token-12-15" morph="none" pos="word" start_char="2309">efecto</TOKEN>
<TOKEN end_char="2327" id="token-12-16" morph="none" pos="word" start_char="2316">inflamatorio</TOKEN>
<TOKEN end_char="2330" id="token-12-17" morph="none" pos="word" start_char="2329">en</TOKEN>
<TOKEN end_char="2333" id="token-12-18" morph="none" pos="word" start_char="2332">el</TOKEN>
<TOKEN end_char="2337" id="token-12-19" morph="none" pos="word" start_char="2335">que</TOKEN>
<TOKEN end_char="2340" id="token-12-20" morph="none" pos="word" start_char="2339">la</TOKEN>
<TOKEN end_char="2347" id="token-12-21" morph="none" pos="word" start_char="2342">propia</TOKEN>
<TOKEN end_char="2357" id="token-12-22" morph="none" pos="word" start_char="2349">respuesta</TOKEN>
<TOKEN end_char="2370" id="token-12-23" morph="none" pos="word" start_char="2359">inmunológica</TOKEN>
<TOKEN end_char="2374" id="token-12-24" morph="none" pos="word" start_char="2372">del</TOKEN>
<TOKEN end_char="2382" id="token-12-25" morph="none" pos="word" start_char="2376">enfermo</TOKEN>
<TOKEN end_char="2385" id="token-12-26" morph="none" pos="word" start_char="2384">es</TOKEN>
<TOKEN end_char="2388" id="token-12-27" morph="none" pos="word" start_char="2387">la</TOKEN>
<TOKEN end_char="2392" id="token-12-28" morph="none" pos="word" start_char="2390">que</TOKEN>
<TOKEN end_char="2397" id="token-12-29" morph="none" pos="word" start_char="2394">daña</TOKEN>
<TOKEN end_char="2400" id="token-12-30" morph="none" pos="word" start_char="2399">al</TOKEN>
<TOKEN end_char="2407" id="token-12-31" morph="none" pos="word" start_char="2402">pulmón</TOKEN>
<TOKEN end_char="2408" id="token-12-32" morph="none" pos="punct" start_char="2408">.</TOKEN>
<TRANSLATED_TEXT>Between the eighth and tenth days, some patients develop pneumonia and a predominant inflammatory effect in which the patient's own immune response is that which damages the lung.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2546" id="segment-13" start_char="2410">
<ORIGINAL_TEXT>Con el objetivo de combatir la inflamación se han postulado varios fármacos con la intención de reducir la activación del sistema inmune.</ORIGINAL_TEXT>
<TOKEN end_char="2412" id="token-13-0" morph="none" pos="word" start_char="2410">Con</TOKEN>
<TOKEN end_char="2415" id="token-13-1" morph="none" pos="word" start_char="2414">el</TOKEN>
<TOKEN end_char="2424" id="token-13-2" morph="none" pos="word" start_char="2417">objetivo</TOKEN>
<TOKEN end_char="2427" id="token-13-3" morph="none" pos="word" start_char="2426">de</TOKEN>
<TOKEN end_char="2436" id="token-13-4" morph="none" pos="word" start_char="2429">combatir</TOKEN>
<TOKEN end_char="2439" id="token-13-5" morph="none" pos="word" start_char="2438">la</TOKEN>
<TOKEN end_char="2451" id="token-13-6" morph="none" pos="word" start_char="2441">inflamación</TOKEN>
<TOKEN end_char="2454" id="token-13-7" morph="none" pos="word" start_char="2453">se</TOKEN>
<TOKEN end_char="2458" id="token-13-8" morph="none" pos="word" start_char="2456">han</TOKEN>
<TOKEN end_char="2468" id="token-13-9" morph="none" pos="word" start_char="2460">postulado</TOKEN>
<TOKEN end_char="2475" id="token-13-10" morph="none" pos="word" start_char="2470">varios</TOKEN>
<TOKEN end_char="2484" id="token-13-11" morph="none" pos="word" start_char="2477">fármacos</TOKEN>
<TOKEN end_char="2488" id="token-13-12" morph="none" pos="word" start_char="2486">con</TOKEN>
<TOKEN end_char="2491" id="token-13-13" morph="none" pos="word" start_char="2490">la</TOKEN>
<TOKEN end_char="2501" id="token-13-14" morph="none" pos="word" start_char="2493">intención</TOKEN>
<TOKEN end_char="2504" id="token-13-15" morph="none" pos="word" start_char="2503">de</TOKEN>
<TOKEN end_char="2512" id="token-13-16" morph="none" pos="word" start_char="2506">reducir</TOKEN>
<TOKEN end_char="2515" id="token-13-17" morph="none" pos="word" start_char="2514">la</TOKEN>
<TOKEN end_char="2526" id="token-13-18" morph="none" pos="word" start_char="2517">activación</TOKEN>
<TOKEN end_char="2530" id="token-13-19" morph="none" pos="word" start_char="2528">del</TOKEN>
<TOKEN end_char="2538" id="token-13-20" morph="none" pos="word" start_char="2532">sistema</TOKEN>
<TOKEN end_char="2545" id="token-13-21" morph="none" pos="word" start_char="2540">inmune</TOKEN>
<TOKEN end_char="2546" id="token-13-22" morph="none" pos="punct" start_char="2546">.</TOKEN>
<TRANSLATED_TEXT>To combat inflammation, several drugs have been postulated with the intention of reducing the activation of the immune system.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2652" id="segment-14" start_char="2549">
<ORIGINAL_TEXT>En el Hospital Universitario Quirónsalud Madrid se han utilizado esteroides, tocilizumab y ciclosporina.</ORIGINAL_TEXT>
<TOKEN end_char="2550" id="token-14-0" morph="none" pos="word" start_char="2549">En</TOKEN>
<TOKEN end_char="2553" id="token-14-1" morph="none" pos="word" start_char="2552">el</TOKEN>
<TOKEN end_char="2562" id="token-14-2" morph="none" pos="word" start_char="2555">Hospital</TOKEN>
<TOKEN end_char="2576" id="token-14-3" morph="none" pos="word" start_char="2564">Universitario</TOKEN>
<TOKEN end_char="2588" id="token-14-4" morph="none" pos="word" start_char="2578">Quirónsalud</TOKEN>
<TOKEN end_char="2595" id="token-14-5" morph="none" pos="word" start_char="2590">Madrid</TOKEN>
<TOKEN end_char="2598" id="token-14-6" morph="none" pos="word" start_char="2597">se</TOKEN>
<TOKEN end_char="2602" id="token-14-7" morph="none" pos="word" start_char="2600">han</TOKEN>
<TOKEN end_char="2612" id="token-14-8" morph="none" pos="word" start_char="2604">utilizado</TOKEN>
<TOKEN end_char="2623" id="token-14-9" morph="none" pos="word" start_char="2614">esteroides</TOKEN>
<TOKEN end_char="2624" id="token-14-10" morph="none" pos="punct" start_char="2624">,</TOKEN>
<TOKEN end_char="2636" id="token-14-11" morph="none" pos="word" start_char="2626">tocilizumab</TOKEN>
<TOKEN end_char="2638" id="token-14-12" morph="none" pos="word" start_char="2638">y</TOKEN>
<TOKEN end_char="2651" id="token-14-13" morph="none" pos="word" start_char="2640">ciclosporina</TOKEN>
<TOKEN end_char="2652" id="token-14-14" morph="none" pos="punct" start_char="2652">.</TOKEN>
<TRANSLATED_TEXT>Steroids, tocilizumab and ciclosporin have been used at the University Hospital Quironsaldo Madrid.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2789" id="segment-15" start_char="2654">
<ORIGINAL_TEXT>Este último es un fármaco que posee una acción antirreplicativa del virus y a su vez es interesante porque modifica la respuesta inmune.</ORIGINAL_TEXT>
<TOKEN end_char="2657" id="token-15-0" morph="none" pos="word" start_char="2654">Este</TOKEN>
<TOKEN end_char="2664" id="token-15-1" morph="none" pos="word" start_char="2659">último</TOKEN>
<TOKEN end_char="2667" id="token-15-2" morph="none" pos="word" start_char="2666">es</TOKEN>
<TOKEN end_char="2670" id="token-15-3" morph="none" pos="word" start_char="2669">un</TOKEN>
<TOKEN end_char="2678" id="token-15-4" morph="none" pos="word" start_char="2672">fármaco</TOKEN>
<TOKEN end_char="2682" id="token-15-5" morph="none" pos="word" start_char="2680">que</TOKEN>
<TOKEN end_char="2688" id="token-15-6" morph="none" pos="word" start_char="2684">posee</TOKEN>
<TOKEN end_char="2692" id="token-15-7" morph="none" pos="word" start_char="2690">una</TOKEN>
<TOKEN end_char="2699" id="token-15-8" morph="none" pos="word" start_char="2694">acción</TOKEN>
<TOKEN end_char="2716" id="token-15-9" morph="none" pos="word" start_char="2701">antirreplicativa</TOKEN>
<TOKEN end_char="2720" id="token-15-10" morph="none" pos="word" start_char="2718">del</TOKEN>
<TOKEN end_char="2726" id="token-15-11" morph="none" pos="word" start_char="2722">virus</TOKEN>
<TOKEN end_char="2728" id="token-15-12" morph="none" pos="word" start_char="2728">y</TOKEN>
<TOKEN end_char="2730" id="token-15-13" morph="none" pos="word" start_char="2730">a</TOKEN>
<TOKEN end_char="2733" id="token-15-14" morph="none" pos="word" start_char="2732">su</TOKEN>
<TOKEN end_char="2737" id="token-15-15" morph="none" pos="word" start_char="2735">vez</TOKEN>
<TOKEN end_char="2740" id="token-15-16" morph="none" pos="word" start_char="2739">es</TOKEN>
<TOKEN end_char="2752" id="token-15-17" morph="none" pos="word" start_char="2742">interesante</TOKEN>
<TOKEN end_char="2759" id="token-15-18" morph="none" pos="word" start_char="2754">porque</TOKEN>
<TOKEN end_char="2768" id="token-15-19" morph="none" pos="word" start_char="2761">modifica</TOKEN>
<TOKEN end_char="2771" id="token-15-20" morph="none" pos="word" start_char="2770">la</TOKEN>
<TOKEN end_char="2781" id="token-15-21" morph="none" pos="word" start_char="2773">respuesta</TOKEN>
<TOKEN end_char="2788" id="token-15-22" morph="none" pos="word" start_char="2783">inmune</TOKEN>
<TOKEN end_char="2789" id="token-15-23" morph="none" pos="punct" start_char="2789">.</TOKEN>
<TRANSLATED_TEXT>The latter is a drug that has an anti-replicative action of the virus and is interesting because it modifies the immune response.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3074" id="segment-16" start_char="2791">
<ORIGINAL_TEXT>Las características de sus pacientes son similares a las descritas por otros grupos: 69 años de media, predominantemente varones, con tasas de comorbilidad asociadas similares (47% hipertensión; 16% diabéticos; 22 por ciento enfermos cardiacos; y 19 por ciento enfermos respiratorios.</ORIGINAL_TEXT>
<TOKEN end_char="2793" id="token-16-0" morph="none" pos="word" start_char="2791">Las</TOKEN>
<TOKEN end_char="2809" id="token-16-1" morph="none" pos="word" start_char="2795">características</TOKEN>
<TOKEN end_char="2812" id="token-16-2" morph="none" pos="word" start_char="2811">de</TOKEN>
<TOKEN end_char="2816" id="token-16-3" morph="none" pos="word" start_char="2814">sus</TOKEN>
<TOKEN end_char="2826" id="token-16-4" morph="none" pos="word" start_char="2818">pacientes</TOKEN>
<TOKEN end_char="2830" id="token-16-5" morph="none" pos="word" start_char="2828">son</TOKEN>
<TOKEN end_char="2840" id="token-16-6" morph="none" pos="word" start_char="2832">similares</TOKEN>
<TOKEN end_char="2842" id="token-16-7" morph="none" pos="word" start_char="2842">a</TOKEN>
<TOKEN end_char="2846" id="token-16-8" morph="none" pos="word" start_char="2844">las</TOKEN>
<TOKEN end_char="2856" id="token-16-9" morph="none" pos="word" start_char="2848">descritas</TOKEN>
<TOKEN end_char="2860" id="token-16-10" morph="none" pos="word" start_char="2858">por</TOKEN>
<TOKEN end_char="2866" id="token-16-11" morph="none" pos="word" start_char="2862">otros</TOKEN>
<TOKEN end_char="2873" id="token-16-12" morph="none" pos="word" start_char="2868">grupos</TOKEN>
<TOKEN end_char="2874" id="token-16-13" morph="none" pos="punct" start_char="2874">:</TOKEN>
<TOKEN end_char="2877" id="token-16-14" morph="none" pos="word" start_char="2876">69</TOKEN>
<TOKEN end_char="2882" id="token-16-15" morph="none" pos="word" start_char="2879">años</TOKEN>
<TOKEN end_char="2885" id="token-16-16" morph="none" pos="word" start_char="2884">de</TOKEN>
<TOKEN end_char="2891" id="token-16-17" morph="none" pos="word" start_char="2887">media</TOKEN>
<TOKEN end_char="2892" id="token-16-18" morph="none" pos="punct" start_char="2892">,</TOKEN>
<TOKEN end_char="2910" id="token-16-19" morph="none" pos="word" start_char="2894">predominantemente</TOKEN>
<TOKEN end_char="2918" id="token-16-20" morph="none" pos="word" start_char="2912">varones</TOKEN>
<TOKEN end_char="2919" id="token-16-21" morph="none" pos="punct" start_char="2919">,</TOKEN>
<TOKEN end_char="2923" id="token-16-22" morph="none" pos="word" start_char="2921">con</TOKEN>
<TOKEN end_char="2929" id="token-16-23" morph="none" pos="word" start_char="2925">tasas</TOKEN>
<TOKEN end_char="2932" id="token-16-24" morph="none" pos="word" start_char="2931">de</TOKEN>
<TOKEN end_char="2945" id="token-16-25" morph="none" pos="word" start_char="2934">comorbilidad</TOKEN>
<TOKEN end_char="2955" id="token-16-26" morph="none" pos="word" start_char="2947">asociadas</TOKEN>
<TOKEN end_char="2965" id="token-16-27" morph="none" pos="word" start_char="2957">similares</TOKEN>
<TOKEN end_char="2967" id="token-16-28" morph="none" pos="punct" start_char="2967">(</TOKEN>
<TOKEN end_char="2969" id="token-16-29" morph="none" pos="word" start_char="2968">47</TOKEN>
<TOKEN end_char="2970" id="token-16-30" morph="none" pos="punct" start_char="2970">%</TOKEN>
<TOKEN end_char="2983" id="token-16-31" morph="none" pos="word" start_char="2972">hipertensión</TOKEN>
<TOKEN end_char="2984" id="token-16-32" morph="none" pos="punct" start_char="2984">;</TOKEN>
<TOKEN end_char="2987" id="token-16-33" morph="none" pos="word" start_char="2986">16</TOKEN>
<TOKEN end_char="2988" id="token-16-34" morph="none" pos="punct" start_char="2988">%</TOKEN>
<TOKEN end_char="2999" id="token-16-35" morph="none" pos="word" start_char="2990">diabéticos</TOKEN>
<TOKEN end_char="3000" id="token-16-36" morph="none" pos="punct" start_char="3000">;</TOKEN>
<TOKEN end_char="3003" id="token-16-37" morph="none" pos="word" start_char="3002">22</TOKEN>
<TOKEN end_char="3007" id="token-16-38" morph="none" pos="word" start_char="3005">por</TOKEN>
<TOKEN end_char="3014" id="token-16-39" morph="none" pos="word" start_char="3009">ciento</TOKEN>
<TOKEN end_char="3023" id="token-16-40" morph="none" pos="word" start_char="3016">enfermos</TOKEN>
<TOKEN end_char="3033" id="token-16-41" morph="none" pos="word" start_char="3025">cardiacos</TOKEN>
<TOKEN end_char="3034" id="token-16-42" morph="none" pos="punct" start_char="3034">;</TOKEN>
<TOKEN end_char="3036" id="token-16-43" morph="none" pos="word" start_char="3036">y</TOKEN>
<TOKEN end_char="3039" id="token-16-44" morph="none" pos="word" start_char="3038">19</TOKEN>
<TOKEN end_char="3043" id="token-16-45" morph="none" pos="word" start_char="3041">por</TOKEN>
<TOKEN end_char="3050" id="token-16-46" morph="none" pos="word" start_char="3045">ciento</TOKEN>
<TOKEN end_char="3059" id="token-16-47" morph="none" pos="word" start_char="3052">enfermos</TOKEN>
<TOKEN end_char="3073" id="token-16-48" morph="none" pos="word" start_char="3061">respiratorios</TOKEN>
<TOKEN end_char="3074" id="token-16-49" morph="none" pos="punct" start_char="3074">.</TOKEN>
<TRANSLATED_TEXT>The characteristics of their patients are similar to those described by other groups: 69 average years, predominantly male, with similar associated comorbidity rates (47% hypertension; 16% diabetic; 22% heart disease; and 19% respiratory disease.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3203" id="segment-17" start_char="3076">
<ORIGINAL_TEXT>En su trabajo, han evaluado estadísticamente las variables que podrían estar asociadas al fallecimiento o supervivencia al alta.</ORIGINAL_TEXT>
<TOKEN end_char="3077" id="token-17-0" morph="none" pos="word" start_char="3076">En</TOKEN>
<TOKEN end_char="3080" id="token-17-1" morph="none" pos="word" start_char="3079">su</TOKEN>
<TOKEN end_char="3088" id="token-17-2" morph="none" pos="word" start_char="3082">trabajo</TOKEN>
<TOKEN end_char="3089" id="token-17-3" morph="none" pos="punct" start_char="3089">,</TOKEN>
<TOKEN end_char="3093" id="token-17-4" morph="none" pos="word" start_char="3091">han</TOKEN>
<TOKEN end_char="3102" id="token-17-5" morph="none" pos="word" start_char="3095">evaluado</TOKEN>
<TOKEN end_char="3119" id="token-17-6" morph="none" pos="word" start_char="3104">estadísticamente</TOKEN>
<TOKEN end_char="3123" id="token-17-7" morph="none" pos="word" start_char="3121">las</TOKEN>
<TOKEN end_char="3133" id="token-17-8" morph="none" pos="word" start_char="3125">variables</TOKEN>
<TOKEN end_char="3137" id="token-17-9" morph="none" pos="word" start_char="3135">que</TOKEN>
<TOKEN end_char="3145" id="token-17-10" morph="none" pos="word" start_char="3139">podrían</TOKEN>
<TOKEN end_char="3151" id="token-17-11" morph="none" pos="word" start_char="3147">estar</TOKEN>
<TOKEN end_char="3161" id="token-17-12" morph="none" pos="word" start_char="3153">asociadas</TOKEN>
<TOKEN end_char="3164" id="token-17-13" morph="none" pos="word" start_char="3163">al</TOKEN>
<TOKEN end_char="3178" id="token-17-14" morph="none" pos="word" start_char="3166">fallecimiento</TOKEN>
<TOKEN end_char="3180" id="token-17-15" morph="none" pos="word" start_char="3180">o</TOKEN>
<TOKEN end_char="3194" id="token-17-16" morph="none" pos="word" start_char="3182">supervivencia</TOKEN>
<TOKEN end_char="3197" id="token-17-17" morph="none" pos="word" start_char="3196">al</TOKEN>
<TOKEN end_char="3202" id="token-17-18" morph="none" pos="word" start_char="3199">alta</TOKEN>
<TOKEN end_char="3203" id="token-17-19" morph="none" pos="punct" start_char="3203">.</TOKEN>
<TRANSLATED_TEXT>In their work, they have statistically evaluated variables that could be associated with death or survival at high.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3310" id="segment-18" start_char="3206">
<ORIGINAL_TEXT>El doctor Carnevali advierte de que la enfermedad por coronavirus "aún no tiene un tratamiento estándar".</ORIGINAL_TEXT>
<TOKEN end_char="3207" id="token-18-0" morph="none" pos="word" start_char="3206">El</TOKEN>
<TOKEN end_char="3214" id="token-18-1" morph="none" pos="word" start_char="3209">doctor</TOKEN>
<TOKEN end_char="3224" id="token-18-2" morph="none" pos="word" start_char="3216">Carnevali</TOKEN>
<TOKEN end_char="3233" id="token-18-3" morph="none" pos="word" start_char="3226">advierte</TOKEN>
<TOKEN end_char="3236" id="token-18-4" morph="none" pos="word" start_char="3235">de</TOKEN>
<TOKEN end_char="3240" id="token-18-5" morph="none" pos="word" start_char="3238">que</TOKEN>
<TOKEN end_char="3243" id="token-18-6" morph="none" pos="word" start_char="3242">la</TOKEN>
<TOKEN end_char="3254" id="token-18-7" morph="none" pos="word" start_char="3245">enfermedad</TOKEN>
<TOKEN end_char="3258" id="token-18-8" morph="none" pos="word" start_char="3256">por</TOKEN>
<TOKEN end_char="3270" id="token-18-9" morph="none" pos="word" start_char="3260">coronavirus</TOKEN>
<TOKEN end_char="3272" id="token-18-10" morph="none" pos="punct" start_char="3272">"</TOKEN>
<TOKEN end_char="3275" id="token-18-11" morph="none" pos="word" start_char="3273">aún</TOKEN>
<TOKEN end_char="3278" id="token-18-12" morph="none" pos="word" start_char="3277">no</TOKEN>
<TOKEN end_char="3284" id="token-18-13" morph="none" pos="word" start_char="3280">tiene</TOKEN>
<TOKEN end_char="3287" id="token-18-14" morph="none" pos="word" start_char="3286">un</TOKEN>
<TOKEN end_char="3299" id="token-18-15" morph="none" pos="word" start_char="3289">tratamiento</TOKEN>
<TOKEN end_char="3308" id="token-18-16" morph="none" pos="word" start_char="3301">estándar</TOKEN>
<TOKEN end_char="3310" id="token-18-17" morph="none" pos="punct" start_char="3309">".</TOKEN>
<TRANSLATED_TEXT>Dr. Carnevali warns that coronavirus disease "does not yet have a standard treatment."</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3486" id="segment-19" start_char="3312">
<ORIGINAL_TEXT>"Durante la primera etapa de la pandemia utilizamos terapias sobre las que teníamos una razonable esperanza de que tuvieran efecto, pero sin ensayos clínicos que los avalaran.</ORIGINAL_TEXT>
<TOKEN end_char="3312" id="token-19-0" morph="none" pos="punct" start_char="3312">"</TOKEN>
<TOKEN end_char="3319" id="token-19-1" morph="none" pos="word" start_char="3313">Durante</TOKEN>
<TOKEN end_char="3322" id="token-19-2" morph="none" pos="word" start_char="3321">la</TOKEN>
<TOKEN end_char="3330" id="token-19-3" morph="none" pos="word" start_char="3324">primera</TOKEN>
<TOKEN end_char="3336" id="token-19-4" morph="none" pos="word" start_char="3332">etapa</TOKEN>
<TOKEN end_char="3339" id="token-19-5" morph="none" pos="word" start_char="3338">de</TOKEN>
<TOKEN end_char="3342" id="token-19-6" morph="none" pos="word" start_char="3341">la</TOKEN>
<TOKEN end_char="3351" id="token-19-7" morph="none" pos="word" start_char="3344">pandemia</TOKEN>
<TOKEN end_char="3362" id="token-19-8" morph="none" pos="word" start_char="3353">utilizamos</TOKEN>
<TOKEN end_char="3371" id="token-19-9" morph="none" pos="word" start_char="3364">terapias</TOKEN>
<TOKEN end_char="3377" id="token-19-10" morph="none" pos="word" start_char="3373">sobre</TOKEN>
<TOKEN end_char="3381" id="token-19-11" morph="none" pos="word" start_char="3379">las</TOKEN>
<TOKEN end_char="3385" id="token-19-12" morph="none" pos="word" start_char="3383">que</TOKEN>
<TOKEN end_char="3394" id="token-19-13" morph="none" pos="word" start_char="3387">teníamos</TOKEN>
<TOKEN end_char="3398" id="token-19-14" morph="none" pos="word" start_char="3396">una</TOKEN>
<TOKEN end_char="3408" id="token-19-15" morph="none" pos="word" start_char="3400">razonable</TOKEN>
<TOKEN end_char="3418" id="token-19-16" morph="none" pos="word" start_char="3410">esperanza</TOKEN>
<TOKEN end_char="3421" id="token-19-17" morph="none" pos="word" start_char="3420">de</TOKEN>
<TOKEN end_char="3425" id="token-19-18" morph="none" pos="word" start_char="3423">que</TOKEN>
<TOKEN end_char="3434" id="token-19-19" morph="none" pos="word" start_char="3427">tuvieran</TOKEN>
<TOKEN end_char="3441" id="token-19-20" morph="none" pos="word" start_char="3436">efecto</TOKEN>
<TOKEN end_char="3442" id="token-19-21" morph="none" pos="punct" start_char="3442">,</TOKEN>
<TOKEN end_char="3447" id="token-19-22" morph="none" pos="word" start_char="3444">pero</TOKEN>
<TOKEN end_char="3451" id="token-19-23" morph="none" pos="word" start_char="3449">sin</TOKEN>
<TOKEN end_char="3459" id="token-19-24" morph="none" pos="word" start_char="3453">ensayos</TOKEN>
<TOKEN end_char="3468" id="token-19-25" morph="none" pos="word" start_char="3461">clínicos</TOKEN>
<TOKEN end_char="3472" id="token-19-26" morph="none" pos="word" start_char="3470">que</TOKEN>
<TOKEN end_char="3476" id="token-19-27" morph="none" pos="word" start_char="3474">los</TOKEN>
<TOKEN end_char="3485" id="token-19-28" morph="none" pos="word" start_char="3478">avalaran</TOKEN>
<TOKEN end_char="3486" id="token-19-29" morph="none" pos="punct" start_char="3486">.</TOKEN>
<TRANSLATED_TEXT>During the first stage of the pandemic we used therapies on which we had a reasonable expectation that they would have effect, but without clinical trials to validate them.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3720" id="segment-20" start_char="3488">
<ORIGINAL_TEXT>Se utilizaron antimaláricos como la hidroxicloroquina, antivirales como el Lopinavir-ritonavir; antibióticos; corticoides y fármacos que actúan en la fase inflamatoria de la enfermedad como el tozilizumab y la ciclosporina", explica.</ORIGINAL_TEXT>
<TOKEN end_char="3489" id="token-20-0" morph="none" pos="word" start_char="3488">Se</TOKEN>
<TOKEN end_char="3500" id="token-20-1" morph="none" pos="word" start_char="3491">utilizaron</TOKEN>
<TOKEN end_char="3514" id="token-20-2" morph="none" pos="word" start_char="3502">antimaláricos</TOKEN>
<TOKEN end_char="3519" id="token-20-3" morph="none" pos="word" start_char="3516">como</TOKEN>
<TOKEN end_char="3522" id="token-20-4" morph="none" pos="word" start_char="3521">la</TOKEN>
<TOKEN end_char="3540" id="token-20-5" morph="none" pos="word" start_char="3524">hidroxicloroquina</TOKEN>
<TOKEN end_char="3541" id="token-20-6" morph="none" pos="punct" start_char="3541">,</TOKEN>
<TOKEN end_char="3553" id="token-20-7" morph="none" pos="word" start_char="3543">antivirales</TOKEN>
<TOKEN end_char="3558" id="token-20-8" morph="none" pos="word" start_char="3555">como</TOKEN>
<TOKEN end_char="3561" id="token-20-9" morph="none" pos="word" start_char="3560">el</TOKEN>
<TOKEN end_char="3581" id="token-20-10" morph="none" pos="unknown" start_char="3563">Lopinavir-ritonavir</TOKEN>
<TOKEN end_char="3582" id="token-20-11" morph="none" pos="punct" start_char="3582">;</TOKEN>
<TOKEN end_char="3595" id="token-20-12" morph="none" pos="word" start_char="3584">antibióticos</TOKEN>
<TOKEN end_char="3596" id="token-20-13" morph="none" pos="punct" start_char="3596">;</TOKEN>
<TOKEN end_char="3608" id="token-20-14" morph="none" pos="word" start_char="3598">corticoides</TOKEN>
<TOKEN end_char="3610" id="token-20-15" morph="none" pos="word" start_char="3610">y</TOKEN>
<TOKEN end_char="3619" id="token-20-16" morph="none" pos="word" start_char="3612">fármacos</TOKEN>
<TOKEN end_char="3623" id="token-20-17" morph="none" pos="word" start_char="3621">que</TOKEN>
<TOKEN end_char="3630" id="token-20-18" morph="none" pos="word" start_char="3625">actúan</TOKEN>
<TOKEN end_char="3633" id="token-20-19" morph="none" pos="word" start_char="3632">en</TOKEN>
<TOKEN end_char="3636" id="token-20-20" morph="none" pos="word" start_char="3635">la</TOKEN>
<TOKEN end_char="3641" id="token-20-21" morph="none" pos="word" start_char="3638">fase</TOKEN>
<TOKEN end_char="3654" id="token-20-22" morph="none" pos="word" start_char="3643">inflamatoria</TOKEN>
<TOKEN end_char="3657" id="token-20-23" morph="none" pos="word" start_char="3656">de</TOKEN>
<TOKEN end_char="3660" id="token-20-24" morph="none" pos="word" start_char="3659">la</TOKEN>
<TOKEN end_char="3671" id="token-20-25" morph="none" pos="word" start_char="3662">enfermedad</TOKEN>
<TOKEN end_char="3676" id="token-20-26" morph="none" pos="word" start_char="3673">como</TOKEN>
<TOKEN end_char="3679" id="token-20-27" morph="none" pos="word" start_char="3678">el</TOKEN>
<TOKEN end_char="3691" id="token-20-28" morph="none" pos="word" start_char="3681">tozilizumab</TOKEN>
<TOKEN end_char="3693" id="token-20-29" morph="none" pos="word" start_char="3693">y</TOKEN>
<TOKEN end_char="3696" id="token-20-30" morph="none" pos="word" start_char="3695">la</TOKEN>
<TOKEN end_char="3709" id="token-20-31" morph="none" pos="word" start_char="3698">ciclosporina</TOKEN>
<TOKEN end_char="3711" id="token-20-32" morph="none" pos="punct" start_char="3710">",</TOKEN>
<TOKEN end_char="3719" id="token-20-33" morph="none" pos="word" start_char="3713">explica</TOKEN>
<TOKEN end_char="3720" id="token-20-34" morph="none" pos="punct" start_char="3720">.</TOKEN>
<TRANSLATED_TEXT>Antimalarial drugs such as hydroxychloroquine, antiviral drugs such as lopinavir-ritonavir, antibiotics, corticosteroids and drugs acting in the inflammatory phase of the disease such as tosilizumab and ciclosporin were used, "he explains.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3891" id="segment-21" start_char="3722">
<ORIGINAL_TEXT>"El hallazgo más sorprendente de nuestro estudio es que los pacientes que recibieron ciclosporina tuvieron una supervivencia mayor respecto a los que no la habían tomado.</ORIGINAL_TEXT>
<TOKEN end_char="3722" id="token-21-0" morph="none" pos="punct" start_char="3722">"</TOKEN>
<TOKEN end_char="3724" id="token-21-1" morph="none" pos="word" start_char="3723">El</TOKEN>
<TOKEN end_char="3733" id="token-21-2" morph="none" pos="word" start_char="3726">hallazgo</TOKEN>
<TOKEN end_char="3737" id="token-21-3" morph="none" pos="word" start_char="3735">más</TOKEN>
<TOKEN end_char="3750" id="token-21-4" morph="none" pos="word" start_char="3739">sorprendente</TOKEN>
<TOKEN end_char="3753" id="token-21-5" morph="none" pos="word" start_char="3752">de</TOKEN>
<TOKEN end_char="3761" id="token-21-6" morph="none" pos="word" start_char="3755">nuestro</TOKEN>
<TOKEN end_char="3769" id="token-21-7" morph="none" pos="word" start_char="3763">estudio</TOKEN>
<TOKEN end_char="3772" id="token-21-8" morph="none" pos="word" start_char="3771">es</TOKEN>
<TOKEN end_char="3776" id="token-21-9" morph="none" pos="word" start_char="3774">que</TOKEN>
<TOKEN end_char="3780" id="token-21-10" morph="none" pos="word" start_char="3778">los</TOKEN>
<TOKEN end_char="3790" id="token-21-11" morph="none" pos="word" start_char="3782">pacientes</TOKEN>
<TOKEN end_char="3794" id="token-21-12" morph="none" pos="word" start_char="3792">que</TOKEN>
<TOKEN end_char="3805" id="token-21-13" morph="none" pos="word" start_char="3796">recibieron</TOKEN>
<TOKEN end_char="3818" id="token-21-14" morph="none" pos="word" start_char="3807">ciclosporina</TOKEN>
<TOKEN end_char="3827" id="token-21-15" morph="none" pos="word" start_char="3820">tuvieron</TOKEN>
<TOKEN end_char="3831" id="token-21-16" morph="none" pos="word" start_char="3829">una</TOKEN>
<TOKEN end_char="3845" id="token-21-17" morph="none" pos="word" start_char="3833">supervivencia</TOKEN>
<TOKEN end_char="3851" id="token-21-18" morph="none" pos="word" start_char="3847">mayor</TOKEN>
<TOKEN end_char="3860" id="token-21-19" morph="none" pos="word" start_char="3853">respecto</TOKEN>
<TOKEN end_char="3862" id="token-21-20" morph="none" pos="word" start_char="3862">a</TOKEN>
<TOKEN end_char="3866" id="token-21-21" morph="none" pos="word" start_char="3864">los</TOKEN>
<TOKEN end_char="3870" id="token-21-22" morph="none" pos="word" start_char="3868">que</TOKEN>
<TOKEN end_char="3873" id="token-21-23" morph="none" pos="word" start_char="3872">no</TOKEN>
<TOKEN end_char="3876" id="token-21-24" morph="none" pos="word" start_char="3875">la</TOKEN>
<TOKEN end_char="3883" id="token-21-25" morph="none" pos="word" start_char="3878">habían</TOKEN>
<TOKEN end_char="3890" id="token-21-26" morph="none" pos="word" start_char="3885">tomado</TOKEN>
<TOKEN end_char="3891" id="token-21-27" morph="none" pos="punct" start_char="3891">.</TOKEN>
<TRANSLATED_TEXT>The most surprising finding from our study is that patients who received ciclosporin had a higher survival rate than those who did not.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3954" id="segment-22" start_char="3893">
<ORIGINAL_TEXT>Sin embargo, los resultados hay que tomarlos con precauciones.</ORIGINAL_TEXT>
<TOKEN end_char="3895" id="token-22-0" morph="none" pos="word" start_char="3893">Sin</TOKEN>
<TOKEN end_char="3903" id="token-22-1" morph="none" pos="word" start_char="3897">embargo</TOKEN>
<TOKEN end_char="3904" id="token-22-2" morph="none" pos="punct" start_char="3904">,</TOKEN>
<TOKEN end_char="3908" id="token-22-3" morph="none" pos="word" start_char="3906">los</TOKEN>
<TOKEN end_char="3919" id="token-22-4" morph="none" pos="word" start_char="3910">resultados</TOKEN>
<TOKEN end_char="3923" id="token-22-5" morph="none" pos="word" start_char="3921">hay</TOKEN>
<TOKEN end_char="3927" id="token-22-6" morph="none" pos="word" start_char="3925">que</TOKEN>
<TOKEN end_char="3936" id="token-22-7" morph="none" pos="word" start_char="3929">tomarlos</TOKEN>
<TOKEN end_char="3940" id="token-22-8" morph="none" pos="word" start_char="3938">con</TOKEN>
<TOKEN end_char="3953" id="token-22-9" morph="none" pos="word" start_char="3942">precauciones</TOKEN>
<TOKEN end_char="3954" id="token-22-10" morph="none" pos="punct" start_char="3954">.</TOKEN>
<TRANSLATED_TEXT>However, the results should be taken with caution.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4062" id="segment-23" start_char="3956">
<ORIGINAL_TEXT>Nuestro estudio es retrospectivo, no es un estudio randomizado doble ciego que comparara fármaco a fármaco.</ORIGINAL_TEXT>
<TOKEN end_char="3962" id="token-23-0" morph="none" pos="word" start_char="3956">Nuestro</TOKEN>
<TOKEN end_char="3970" id="token-23-1" morph="none" pos="word" start_char="3964">estudio</TOKEN>
<TOKEN end_char="3973" id="token-23-2" morph="none" pos="word" start_char="3972">es</TOKEN>
<TOKEN end_char="3987" id="token-23-3" morph="none" pos="word" start_char="3975">retrospectivo</TOKEN>
<TOKEN end_char="3988" id="token-23-4" morph="none" pos="punct" start_char="3988">,</TOKEN>
<TOKEN end_char="3991" id="token-23-5" morph="none" pos="word" start_char="3990">no</TOKEN>
<TOKEN end_char="3994" id="token-23-6" morph="none" pos="word" start_char="3993">es</TOKEN>
<TOKEN end_char="3997" id="token-23-7" morph="none" pos="word" start_char="3996">un</TOKEN>
<TOKEN end_char="4005" id="token-23-8" morph="none" pos="word" start_char="3999">estudio</TOKEN>
<TOKEN end_char="4017" id="token-23-9" morph="none" pos="word" start_char="4007">randomizado</TOKEN>
<TOKEN end_char="4023" id="token-23-10" morph="none" pos="word" start_char="4019">doble</TOKEN>
<TOKEN end_char="4029" id="token-23-11" morph="none" pos="word" start_char="4025">ciego</TOKEN>
<TOKEN end_char="4033" id="token-23-12" morph="none" pos="word" start_char="4031">que</TOKEN>
<TOKEN end_char="4043" id="token-23-13" morph="none" pos="word" start_char="4035">comparara</TOKEN>
<TOKEN end_char="4051" id="token-23-14" morph="none" pos="word" start_char="4045">fármaco</TOKEN>
<TOKEN end_char="4053" id="token-23-15" morph="none" pos="word" start_char="4053">a</TOKEN>
<TOKEN end_char="4061" id="token-23-16" morph="none" pos="word" start_char="4055">fármaco</TOKEN>
<TOKEN end_char="4062" id="token-23-17" morph="none" pos="punct" start_char="4062">.</TOKEN>
<TRANSLATED_TEXT>Our study is retrospective, not a double-blind randomized trial that compared a drug to a drug.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4295" id="segment-24" start_char="4064">
<ORIGINAL_TEXT>Lo que sí hemos comprobado es que los pacientes que han recibido ciclosporina no son esencialmente diferentes al resto de pacientes, sufrían unas comorbilidades similares y sin embargo, su resultado clínico ha sido mejor", concluye.</ORIGINAL_TEXT>
<TOKEN end_char="4065" id="token-24-0" morph="none" pos="word" start_char="4064">Lo</TOKEN>
<TOKEN end_char="4069" id="token-24-1" morph="none" pos="word" start_char="4067">que</TOKEN>
<TOKEN end_char="4072" id="token-24-2" morph="none" pos="word" start_char="4071">sí</TOKEN>
<TOKEN end_char="4078" id="token-24-3" morph="none" pos="word" start_char="4074">hemos</TOKEN>
<TOKEN end_char="4089" id="token-24-4" morph="none" pos="word" start_char="4080">comprobado</TOKEN>
<TOKEN end_char="4092" id="token-24-5" morph="none" pos="word" start_char="4091">es</TOKEN>
<TOKEN end_char="4096" id="token-24-6" morph="none" pos="word" start_char="4094">que</TOKEN>
<TOKEN end_char="4100" id="token-24-7" morph="none" pos="word" start_char="4098">los</TOKEN>
<TOKEN end_char="4110" id="token-24-8" morph="none" pos="word" start_char="4102">pacientes</TOKEN>
<TOKEN end_char="4114" id="token-24-9" morph="none" pos="word" start_char="4112">que</TOKEN>
<TOKEN end_char="4118" id="token-24-10" morph="none" pos="word" start_char="4116">han</TOKEN>
<TOKEN end_char="4127" id="token-24-11" morph="none" pos="word" start_char="4120">recibido</TOKEN>
<TOKEN end_char="4140" id="token-24-12" morph="none" pos="word" start_char="4129">ciclosporina</TOKEN>
<TOKEN end_char="4143" id="token-24-13" morph="none" pos="word" start_char="4142">no</TOKEN>
<TOKEN end_char="4147" id="token-24-14" morph="none" pos="word" start_char="4145">son</TOKEN>
<TOKEN end_char="4161" id="token-24-15" morph="none" pos="word" start_char="4149">esencialmente</TOKEN>
<TOKEN end_char="4172" id="token-24-16" morph="none" pos="word" start_char="4163">diferentes</TOKEN>
<TOKEN end_char="4175" id="token-24-17" morph="none" pos="word" start_char="4174">al</TOKEN>
<TOKEN end_char="4181" id="token-24-18" morph="none" pos="word" start_char="4177">resto</TOKEN>
<TOKEN end_char="4184" id="token-24-19" morph="none" pos="word" start_char="4183">de</TOKEN>
<TOKEN end_char="4194" id="token-24-20" morph="none" pos="word" start_char="4186">pacientes</TOKEN>
<TOKEN end_char="4195" id="token-24-21" morph="none" pos="punct" start_char="4195">,</TOKEN>
<TOKEN end_char="4203" id="token-24-22" morph="none" pos="word" start_char="4197">sufrían</TOKEN>
<TOKEN end_char="4208" id="token-24-23" morph="none" pos="word" start_char="4205">unas</TOKEN>
<TOKEN end_char="4223" id="token-24-24" morph="none" pos="word" start_char="4210">comorbilidades</TOKEN>
<TOKEN end_char="4233" id="token-24-25" morph="none" pos="word" start_char="4225">similares</TOKEN>
<TOKEN end_char="4235" id="token-24-26" morph="none" pos="word" start_char="4235">y</TOKEN>
<TOKEN end_char="4239" id="token-24-27" morph="none" pos="word" start_char="4237">sin</TOKEN>
<TOKEN end_char="4247" id="token-24-28" morph="none" pos="word" start_char="4241">embargo</TOKEN>
<TOKEN end_char="4248" id="token-24-29" morph="none" pos="punct" start_char="4248">,</TOKEN>
<TOKEN end_char="4251" id="token-24-30" morph="none" pos="word" start_char="4250">su</TOKEN>
<TOKEN end_char="4261" id="token-24-31" morph="none" pos="word" start_char="4253">resultado</TOKEN>
<TOKEN end_char="4269" id="token-24-32" morph="none" pos="word" start_char="4263">clínico</TOKEN>
<TOKEN end_char="4272" id="token-24-33" morph="none" pos="word" start_char="4271">ha</TOKEN>
<TOKEN end_char="4277" id="token-24-34" morph="none" pos="word" start_char="4274">sido</TOKEN>
<TOKEN end_char="4283" id="token-24-35" morph="none" pos="word" start_char="4279">mejor</TOKEN>
<TOKEN end_char="4285" id="token-24-36" morph="none" pos="punct" start_char="4284">",</TOKEN>
<TOKEN end_char="4294" id="token-24-37" morph="none" pos="word" start_char="4287">concluye</TOKEN>
<TOKEN end_char="4295" id="token-24-38" morph="none" pos="punct" start_char="4295">.</TOKEN>
<TRANSLATED_TEXT>What we have proven is that patients who have received ciclosporin are not essentially different from the rest of the patients, they had similar comorbidities and yet their clinical outcome has been better, "he concludes.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4443" id="segment-25" start_char="4298">
<ORIGINAL_TEXT>Para llevar a cabo este estudio se analizaron diferentes variables que pudieran influir en los resultados de los pacientes afectados por Covid-19.</ORIGINAL_TEXT>
<TOKEN end_char="4301" id="token-25-0" morph="none" pos="word" start_char="4298">Para</TOKEN>
<TOKEN end_char="4308" id="token-25-1" morph="none" pos="word" start_char="4303">llevar</TOKEN>
<TOKEN end_char="4310" id="token-25-2" morph="none" pos="word" start_char="4310">a</TOKEN>
<TOKEN end_char="4315" id="token-25-3" morph="none" pos="word" start_char="4312">cabo</TOKEN>
<TOKEN end_char="4320" id="token-25-4" morph="none" pos="word" start_char="4317">este</TOKEN>
<TOKEN end_char="4328" id="token-25-5" morph="none" pos="word" start_char="4322">estudio</TOKEN>
<TOKEN end_char="4331" id="token-25-6" morph="none" pos="word" start_char="4330">se</TOKEN>
<TOKEN end_char="4342" id="token-25-7" morph="none" pos="word" start_char="4333">analizaron</TOKEN>
<TOKEN end_char="4353" id="token-25-8" morph="none" pos="word" start_char="4344">diferentes</TOKEN>
<TOKEN end_char="4363" id="token-25-9" morph="none" pos="word" start_char="4355">variables</TOKEN>
<TOKEN end_char="4367" id="token-25-10" morph="none" pos="word" start_char="4365">que</TOKEN>
<TOKEN end_char="4376" id="token-25-11" morph="none" pos="word" start_char="4369">pudieran</TOKEN>
<TOKEN end_char="4384" id="token-25-12" morph="none" pos="word" start_char="4378">influir</TOKEN>
<TOKEN end_char="4387" id="token-25-13" morph="none" pos="word" start_char="4386">en</TOKEN>
<TOKEN end_char="4391" id="token-25-14" morph="none" pos="word" start_char="4389">los</TOKEN>
<TOKEN end_char="4402" id="token-25-15" morph="none" pos="word" start_char="4393">resultados</TOKEN>
<TOKEN end_char="4405" id="token-25-16" morph="none" pos="word" start_char="4404">de</TOKEN>
<TOKEN end_char="4409" id="token-25-17" morph="none" pos="word" start_char="4407">los</TOKEN>
<TOKEN end_char="4419" id="token-25-18" morph="none" pos="word" start_char="4411">pacientes</TOKEN>
<TOKEN end_char="4429" id="token-25-19" morph="none" pos="word" start_char="4421">afectados</TOKEN>
<TOKEN end_char="4433" id="token-25-20" morph="none" pos="word" start_char="4431">por</TOKEN>
<TOKEN end_char="4442" id="token-25-21" morph="none" pos="unknown" start_char="4435">Covid-19</TOKEN>
<TOKEN end_char="4443" id="token-25-22" morph="none" pos="punct" start_char="4443">.</TOKEN>
<TRANSLATED_TEXT>To carry out this study, different variables were analysed that could influence the outcomes of patients affected by Covid-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4826" id="segment-26" start_char="4445">
<ORIGINAL_TEXT>"Realizamos un análisis de factores que pudieran influir sobre la mortalidad del paciente como la edad, el score radiológico, la necesidad o no y el tipo de ventilación mecánica utilizada, los tratamientos… primero en un modelo univariante y luego en un modelo ajustado y observamos que el hecho de que los pacientes fueran tratados con ciclosporina protegía frente a la mortalidad.</ORIGINAL_TEXT>
<TOKEN end_char="4445" id="token-26-0" morph="none" pos="punct" start_char="4445">"</TOKEN>
<TOKEN end_char="4455" id="token-26-1" morph="none" pos="word" start_char="4446">Realizamos</TOKEN>
<TOKEN end_char="4458" id="token-26-2" morph="none" pos="word" start_char="4457">un</TOKEN>
<TOKEN end_char="4467" id="token-26-3" morph="none" pos="word" start_char="4460">análisis</TOKEN>
<TOKEN end_char="4470" id="token-26-4" morph="none" pos="word" start_char="4469">de</TOKEN>
<TOKEN end_char="4479" id="token-26-5" morph="none" pos="word" start_char="4472">factores</TOKEN>
<TOKEN end_char="4483" id="token-26-6" morph="none" pos="word" start_char="4481">que</TOKEN>
<TOKEN end_char="4492" id="token-26-7" morph="none" pos="word" start_char="4485">pudieran</TOKEN>
<TOKEN end_char="4500" id="token-26-8" morph="none" pos="word" start_char="4494">influir</TOKEN>
<TOKEN end_char="4506" id="token-26-9" morph="none" pos="word" start_char="4502">sobre</TOKEN>
<TOKEN end_char="4509" id="token-26-10" morph="none" pos="word" start_char="4508">la</TOKEN>
<TOKEN end_char="4520" id="token-26-11" morph="none" pos="word" start_char="4511">mortalidad</TOKEN>
<TOKEN end_char="4524" id="token-26-12" morph="none" pos="word" start_char="4522">del</TOKEN>
<TOKEN end_char="4533" id="token-26-13" morph="none" pos="word" start_char="4526">paciente</TOKEN>
<TOKEN end_char="4538" id="token-26-14" morph="none" pos="word" start_char="4535">como</TOKEN>
<TOKEN end_char="4541" id="token-26-15" morph="none" pos="word" start_char="4540">la</TOKEN>
<TOKEN end_char="4546" id="token-26-16" morph="none" pos="word" start_char="4543">edad</TOKEN>
<TOKEN end_char="4547" id="token-26-17" morph="none" pos="punct" start_char="4547">,</TOKEN>
<TOKEN end_char="4550" id="token-26-18" morph="none" pos="word" start_char="4549">el</TOKEN>
<TOKEN end_char="4556" id="token-26-19" morph="none" pos="word" start_char="4552">score</TOKEN>
<TOKEN end_char="4568" id="token-26-20" morph="none" pos="word" start_char="4558">radiológico</TOKEN>
<TOKEN end_char="4569" id="token-26-21" morph="none" pos="punct" start_char="4569">,</TOKEN>
<TOKEN end_char="4572" id="token-26-22" morph="none" pos="word" start_char="4571">la</TOKEN>
<TOKEN end_char="4582" id="token-26-23" morph="none" pos="word" start_char="4574">necesidad</TOKEN>
<TOKEN end_char="4584" id="token-26-24" morph="none" pos="word" start_char="4584">o</TOKEN>
<TOKEN end_char="4587" id="token-26-25" morph="none" pos="word" start_char="4586">no</TOKEN>
<TOKEN end_char="4589" id="token-26-26" morph="none" pos="word" start_char="4589">y</TOKEN>
<TOKEN end_char="4592" id="token-26-27" morph="none" pos="word" start_char="4591">el</TOKEN>
<TOKEN end_char="4597" id="token-26-28" morph="none" pos="word" start_char="4594">tipo</TOKEN>
<TOKEN end_char="4600" id="token-26-29" morph="none" pos="word" start_char="4599">de</TOKEN>
<TOKEN end_char="4612" id="token-26-30" morph="none" pos="word" start_char="4602">ventilación</TOKEN>
<TOKEN end_char="4621" id="token-26-31" morph="none" pos="word" start_char="4614">mecánica</TOKEN>
<TOKEN end_char="4631" id="token-26-32" morph="none" pos="word" start_char="4623">utilizada</TOKEN>
<TOKEN end_char="4632" id="token-26-33" morph="none" pos="punct" start_char="4632">,</TOKEN>
<TOKEN end_char="4636" id="token-26-34" morph="none" pos="word" start_char="4634">los</TOKEN>
<TOKEN end_char="4649" id="token-26-35" morph="none" pos="word" start_char="4638">tratamientos</TOKEN>
<TOKEN end_char="4650" id="token-26-36" morph="none" pos="punct" start_char="4650">…</TOKEN>
<TOKEN end_char="4658" id="token-26-37" morph="none" pos="word" start_char="4652">primero</TOKEN>
<TOKEN end_char="4661" id="token-26-38" morph="none" pos="word" start_char="4660">en</TOKEN>
<TOKEN end_char="4664" id="token-26-39" morph="none" pos="word" start_char="4663">un</TOKEN>
<TOKEN end_char="4671" id="token-26-40" morph="none" pos="word" start_char="4666">modelo</TOKEN>
<TOKEN end_char="4683" id="token-26-41" morph="none" pos="word" start_char="4673">univariante</TOKEN>
<TOKEN end_char="4685" id="token-26-42" morph="none" pos="word" start_char="4685">y</TOKEN>
<TOKEN end_char="4691" id="token-26-43" morph="none" pos="word" start_char="4687">luego</TOKEN>
<TOKEN end_char="4694" id="token-26-44" morph="none" pos="word" start_char="4693">en</TOKEN>
<TOKEN end_char="4697" id="token-26-45" morph="none" pos="word" start_char="4696">un</TOKEN>
<TOKEN end_char="4704" id="token-26-46" morph="none" pos="word" start_char="4699">modelo</TOKEN>
<TOKEN end_char="4713" id="token-26-47" morph="none" pos="word" start_char="4706">ajustado</TOKEN>
<TOKEN end_char="4715" id="token-26-48" morph="none" pos="word" start_char="4715">y</TOKEN>
<TOKEN end_char="4726" id="token-26-49" morph="none" pos="word" start_char="4717">observamos</TOKEN>
<TOKEN end_char="4730" id="token-26-50" morph="none" pos="word" start_char="4728">que</TOKEN>
<TOKEN end_char="4733" id="token-26-51" morph="none" pos="word" start_char="4732">el</TOKEN>
<TOKEN end_char="4739" id="token-26-52" morph="none" pos="word" start_char="4735">hecho</TOKEN>
<TOKEN end_char="4742" id="token-26-53" morph="none" pos="word" start_char="4741">de</TOKEN>
<TOKEN end_char="4746" id="token-26-54" morph="none" pos="word" start_char="4744">que</TOKEN>
<TOKEN end_char="4750" id="token-26-55" morph="none" pos="word" start_char="4748">los</TOKEN>
<TOKEN end_char="4760" id="token-26-56" morph="none" pos="word" start_char="4752">pacientes</TOKEN>
<TOKEN end_char="4767" id="token-26-57" morph="none" pos="word" start_char="4762">fueran</TOKEN>
<TOKEN end_char="4776" id="token-26-58" morph="none" pos="word" start_char="4769">tratados</TOKEN>
<TOKEN end_char="4780" id="token-26-59" morph="none" pos="word" start_char="4778">con</TOKEN>
<TOKEN end_char="4793" id="token-26-60" morph="none" pos="word" start_char="4782">ciclosporina</TOKEN>
<TOKEN end_char="4802" id="token-26-61" morph="none" pos="word" start_char="4795">protegía</TOKEN>
<TOKEN end_char="4809" id="token-26-62" morph="none" pos="word" start_char="4804">frente</TOKEN>
<TOKEN end_char="4811" id="token-26-63" morph="none" pos="word" start_char="4811">a</TOKEN>
<TOKEN end_char="4814" id="token-26-64" morph="none" pos="word" start_char="4813">la</TOKEN>
<TOKEN end_char="4825" id="token-26-65" morph="none" pos="word" start_char="4816">mortalidad</TOKEN>
<TOKEN end_char="4826" id="token-26-66" morph="none" pos="punct" start_char="4826">.</TOKEN>
<TRANSLATED_TEXT>We did an analysis of factors that could influence patient mortality such as age, radiological score, need or not and the type of mechanical ventilation used, treatments... first in a univariate model and then in an adjusted model and observed that the fact that patients were treated with ciclosporin protected against mortality.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="5096" id="segment-27" start_char="4828">
<ORIGINAL_TEXT>De hecho, los pacientes que no habían recibido ciclosporina tenían 4,22 veces más posibilidades de morir que los que habían recibido este tratamiento", detalla Israel J. Thuissard, miembro del Grupo de Asesoramiento Metodológico y Estadístico de la Universidad Europea.</ORIGINAL_TEXT>
<TOKEN end_char="4829" id="token-27-0" morph="none" pos="word" start_char="4828">De</TOKEN>
<TOKEN end_char="4835" id="token-27-1" morph="none" pos="word" start_char="4831">hecho</TOKEN>
<TOKEN end_char="4836" id="token-27-2" morph="none" pos="punct" start_char="4836">,</TOKEN>
<TOKEN end_char="4840" id="token-27-3" morph="none" pos="word" start_char="4838">los</TOKEN>
<TOKEN end_char="4850" id="token-27-4" morph="none" pos="word" start_char="4842">pacientes</TOKEN>
<TOKEN end_char="4854" id="token-27-5" morph="none" pos="word" start_char="4852">que</TOKEN>
<TOKEN end_char="4857" id="token-27-6" morph="none" pos="word" start_char="4856">no</TOKEN>
<TOKEN end_char="4864" id="token-27-7" morph="none" pos="word" start_char="4859">habían</TOKEN>
<TOKEN end_char="4873" id="token-27-8" morph="none" pos="word" start_char="4866">recibido</TOKEN>
<TOKEN end_char="4886" id="token-27-9" morph="none" pos="word" start_char="4875">ciclosporina</TOKEN>
<TOKEN end_char="4893" id="token-27-10" morph="none" pos="word" start_char="4888">tenían</TOKEN>
<TOKEN end_char="4898" id="token-27-11" morph="none" pos="unknown" start_char="4895">4,22</TOKEN>
<TOKEN end_char="4904" id="token-27-12" morph="none" pos="word" start_char="4900">veces</TOKEN>
<TOKEN end_char="4908" id="token-27-13" morph="none" pos="word" start_char="4906">más</TOKEN>
<TOKEN end_char="4922" id="token-27-14" morph="none" pos="word" start_char="4910">posibilidades</TOKEN>
<TOKEN end_char="4925" id="token-27-15" morph="none" pos="word" start_char="4924">de</TOKEN>
<TOKEN end_char="4931" id="token-27-16" morph="none" pos="word" start_char="4927">morir</TOKEN>
<TOKEN end_char="4935" id="token-27-17" morph="none" pos="word" start_char="4933">que</TOKEN>
<TOKEN end_char="4939" id="token-27-18" morph="none" pos="word" start_char="4937">los</TOKEN>
<TOKEN end_char="4943" id="token-27-19" morph="none" pos="word" start_char="4941">que</TOKEN>
<TOKEN end_char="4950" id="token-27-20" morph="none" pos="word" start_char="4945">habían</TOKEN>
<TOKEN end_char="4959" id="token-27-21" morph="none" pos="word" start_char="4952">recibido</TOKEN>
<TOKEN end_char="4964" id="token-27-22" morph="none" pos="word" start_char="4961">este</TOKEN>
<TOKEN end_char="4976" id="token-27-23" morph="none" pos="word" start_char="4966">tratamiento</TOKEN>
<TOKEN end_char="4978" id="token-27-24" morph="none" pos="punct" start_char="4977">",</TOKEN>
<TOKEN end_char="4986" id="token-27-25" morph="none" pos="word" start_char="4980">detalla</TOKEN>
<TOKEN end_char="4993" id="token-27-26" morph="none" pos="word" start_char="4988">Israel</TOKEN>
<TOKEN end_char="4995" id="token-27-27" morph="none" pos="word" start_char="4995">J</TOKEN>
<TOKEN end_char="4996" id="token-27-28" morph="none" pos="punct" start_char="4996">.</TOKEN>
<TOKEN end_char="5006" id="token-27-29" morph="none" pos="word" start_char="4998">Thuissard</TOKEN>
<TOKEN end_char="5007" id="token-27-30" morph="none" pos="punct" start_char="5007">,</TOKEN>
<TOKEN end_char="5015" id="token-27-31" morph="none" pos="word" start_char="5009">miembro</TOKEN>
<TOKEN end_char="5019" id="token-27-32" morph="none" pos="word" start_char="5017">del</TOKEN>
<TOKEN end_char="5025" id="token-27-33" morph="none" pos="word" start_char="5021">Grupo</TOKEN>
<TOKEN end_char="5028" id="token-27-34" morph="none" pos="word" start_char="5027">de</TOKEN>
<TOKEN end_char="5042" id="token-27-35" morph="none" pos="word" start_char="5030">Asesoramiento</TOKEN>
<TOKEN end_char="5055" id="token-27-36" morph="none" pos="word" start_char="5044">Metodológico</TOKEN>
<TOKEN end_char="5057" id="token-27-37" morph="none" pos="word" start_char="5057">y</TOKEN>
<TOKEN end_char="5069" id="token-27-38" morph="none" pos="word" start_char="5059">Estadístico</TOKEN>
<TOKEN end_char="5072" id="token-27-39" morph="none" pos="word" start_char="5071">de</TOKEN>
<TOKEN end_char="5075" id="token-27-40" morph="none" pos="word" start_char="5074">la</TOKEN>
<TOKEN end_char="5087" id="token-27-41" morph="none" pos="word" start_char="5077">Universidad</TOKEN>
<TOKEN end_char="5095" id="token-27-42" morph="none" pos="word" start_char="5089">Europea</TOKEN>
<TOKEN end_char="5096" id="token-27-43" morph="none" pos="punct" start_char="5096">.</TOKEN>
<TRANSLATED_TEXT>In fact, patients who had not received ciclosporin were 4.22 times more likely to die than those who had received this treatment, "explains Israel J. Thuisard, member of the European University's Methodological and Statistical Advisory Group.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="5212" id="segment-28" start_char="5099">
<ORIGINAL_TEXT>El doctor Carnevali asegura que han encontrado "indicios" de que la ciclosporina podría ser un fármaco prometedor.</ORIGINAL_TEXT>
<TOKEN end_char="5100" id="token-28-0" morph="none" pos="word" start_char="5099">El</TOKEN>
<TOKEN end_char="5107" id="token-28-1" morph="none" pos="word" start_char="5102">doctor</TOKEN>
<TOKEN end_char="5117" id="token-28-2" morph="none" pos="word" start_char="5109">Carnevali</TOKEN>
<TOKEN end_char="5125" id="token-28-3" morph="none" pos="word" start_char="5119">asegura</TOKEN>
<TOKEN end_char="5129" id="token-28-4" morph="none" pos="word" start_char="5127">que</TOKEN>
<TOKEN end_char="5133" id="token-28-5" morph="none" pos="word" start_char="5131">han</TOKEN>
<TOKEN end_char="5144" id="token-28-6" morph="none" pos="word" start_char="5135">encontrado</TOKEN>
<TOKEN end_char="5146" id="token-28-7" morph="none" pos="punct" start_char="5146">"</TOKEN>
<TOKEN end_char="5154" id="token-28-8" morph="none" pos="word" start_char="5147">indicios</TOKEN>
<TOKEN end_char="5155" id="token-28-9" morph="none" pos="punct" start_char="5155">"</TOKEN>
<TOKEN end_char="5158" id="token-28-10" morph="none" pos="word" start_char="5157">de</TOKEN>
<TOKEN end_char="5162" id="token-28-11" morph="none" pos="word" start_char="5160">que</TOKEN>
<TOKEN end_char="5165" id="token-28-12" morph="none" pos="word" start_char="5164">la</TOKEN>
<TOKEN end_char="5178" id="token-28-13" morph="none" pos="word" start_char="5167">ciclosporina</TOKEN>
<TOKEN end_char="5185" id="token-28-14" morph="none" pos="word" start_char="5180">podría</TOKEN>
<TOKEN end_char="5189" id="token-28-15" morph="none" pos="word" start_char="5187">ser</TOKEN>
<TOKEN end_char="5192" id="token-28-16" morph="none" pos="word" start_char="5191">un</TOKEN>
<TOKEN end_char="5200" id="token-28-17" morph="none" pos="word" start_char="5194">fármaco</TOKEN>
<TOKEN end_char="5211" id="token-28-18" morph="none" pos="word" start_char="5202">prometedor</TOKEN>
<TOKEN end_char="5212" id="token-28-19" morph="none" pos="punct" start_char="5212">.</TOKEN>
<TRANSLATED_TEXT>Dr. Carnevali says they have found "indications" that ciclosporin could be a promising drug.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="5374" id="segment-29" start_char="5214">
<ORIGINAL_TEXT>"Para confirmar esta hipótesis sería necesario un ensayo clínico en el que se pudiera aleatorizar entre pacientes que tomaran ciclosporina o placebo", sentencia.</ORIGINAL_TEXT>
<TOKEN end_char="5214" id="token-29-0" morph="none" pos="punct" start_char="5214">"</TOKEN>
<TOKEN end_char="5218" id="token-29-1" morph="none" pos="word" start_char="5215">Para</TOKEN>
<TOKEN end_char="5228" id="token-29-2" morph="none" pos="word" start_char="5220">confirmar</TOKEN>
<TOKEN end_char="5233" id="token-29-3" morph="none" pos="word" start_char="5230">esta</TOKEN>
<TOKEN end_char="5243" id="token-29-4" morph="none" pos="word" start_char="5235">hipótesis</TOKEN>
<TOKEN end_char="5249" id="token-29-5" morph="none" pos="word" start_char="5245">sería</TOKEN>
<TOKEN end_char="5259" id="token-29-6" morph="none" pos="word" start_char="5251">necesario</TOKEN>
<TOKEN end_char="5262" id="token-29-7" morph="none" pos="word" start_char="5261">un</TOKEN>
<TOKEN end_char="5269" id="token-29-8" morph="none" pos="word" start_char="5264">ensayo</TOKEN>
<TOKEN end_char="5277" id="token-29-9" morph="none" pos="word" start_char="5271">clínico</TOKEN>
<TOKEN end_char="5280" id="token-29-10" morph="none" pos="word" start_char="5279">en</TOKEN>
<TOKEN end_char="5283" id="token-29-11" morph="none" pos="word" start_char="5282">el</TOKEN>
<TOKEN end_char="5287" id="token-29-12" morph="none" pos="word" start_char="5285">que</TOKEN>
<TOKEN end_char="5290" id="token-29-13" morph="none" pos="word" start_char="5289">se</TOKEN>
<TOKEN end_char="5298" id="token-29-14" morph="none" pos="word" start_char="5292">pudiera</TOKEN>
<TOKEN end_char="5310" id="token-29-15" morph="none" pos="word" start_char="5300">aleatorizar</TOKEN>
<TOKEN end_char="5316" id="token-29-16" morph="none" pos="word" start_char="5312">entre</TOKEN>
<TOKEN end_char="5326" id="token-29-17" morph="none" pos="word" start_char="5318">pacientes</TOKEN>
<TOKEN end_char="5330" id="token-29-18" morph="none" pos="word" start_char="5328">que</TOKEN>
<TOKEN end_char="5338" id="token-29-19" morph="none" pos="word" start_char="5332">tomaran</TOKEN>
<TOKEN end_char="5351" id="token-29-20" morph="none" pos="word" start_char="5340">ciclosporina</TOKEN>
<TOKEN end_char="5353" id="token-29-21" morph="none" pos="word" start_char="5353">o</TOKEN>
<TOKEN end_char="5361" id="token-29-22" morph="none" pos="word" start_char="5355">placebo</TOKEN>
<TOKEN end_char="5363" id="token-29-23" morph="none" pos="punct" start_char="5362">",</TOKEN>
<TOKEN end_char="5373" id="token-29-24" morph="none" pos="word" start_char="5365">sentencia</TOKEN>
<TOKEN end_char="5374" id="token-29-25" morph="none" pos="punct" start_char="5374">.</TOKEN>
<TRANSLATED_TEXT>"To confirm this hypothesis, a clinical trial would be needed in which patients taking ciclosporin or placebo could be randomized," he said.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>